|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
# | Reference Title | Reference Citation |
1. | GOAs Human GO annotations | GOA_HUMAN data from the GO Consortium |
2. | KEGG Annotation Import Pipeline | Pipeline to import KEGG annotations from KEGG into RGD |
3. | Data Import for Chemical-Gene Interactions | RGD automated import pipeline for gene-chemical interactions |
4. | RGD HPO Phenotype Annotation Pipeline | RGD automated import pipeline for human HPO-to-gene-to-disease annotations |
5. | Suppression of tumor suppressor Tsc2 and DNA repair glycosylase Nth1 during spontaneous liver tumorigenesis in Long-Evans Cinnamon rats. | Sajankila SP, etal., Mol Cell Biochem. 2010 May;338(1-2):233-9. doi: 10.1007/s11010-009-0357-1. Epub 2009 Dec 24. |
PMID:8611553 | PMID:8990169 | PMID:9045706 | PMID:9705289 | PMID:9743625 | PMID:9831664 | PMID:9927729 | PMID:10583946 | PMID:10882850 | PMID:11328882 | PMID:11937636 | PMID:12140329 |
PMID:12144783 | PMID:12167705 | PMID:12477932 | PMID:12519758 | PMID:12531031 | PMID:14522981 | PMID:14734554 | PMID:15260972 | PMID:15358233 | PMID:15489334 | PMID:15533839 | PMID:15616553 |
PMID:16111924 | PMID:16446124 | PMID:17150535 | PMID:17353931 | PMID:17923696 | PMID:18307537 | PMID:18515411 | PMID:19414504 | PMID:20226869 | PMID:20522537 | PMID:20574454 | PMID:20834067 |
PMID:20843780 | PMID:20877624 | PMID:21048031 | PMID:21873635 | PMID:22020285 | PMID:22465744 | PMID:22658674 | PMID:22678362 | PMID:22939629 | PMID:23891004 | PMID:24163370 | PMID:24332808 |
PMID:25938944 | PMID:26167880 | PMID:26400813 | PMID:26496610 | PMID:26559593 | PMID:27713038 | PMID:27839712 | PMID:28065597 | PMID:28292631 | PMID:28514442 | PMID:28575236 | PMID:28709015 |
PMID:29522130 | PMID:29610152 | PMID:30207305 | PMID:30552997 | PMID:30554943 | PMID:30649547 | PMID:30753826 | PMID:30804502 | PMID:31091453 | PMID:31227763 | PMID:31470122 | PMID:31527615 |
PMID:31540324 | PMID:32109332 | PMID:32239880 | PMID:32807901 | PMID:32860789 | PMID:32949222 | PMID:33087284 | PMID:33454955 | PMID:33961781 | PMID:34250384 | PMID:34800366 | PMID:34871433 |
PMID:35271311 | PMID:35944360 | PMID:36089195 | PMID:36244648 | PMID:36279116 | PMID:36574265 | PMID:36581342 | PMID:37704626 | PMID:37827155 | PMID:38036545 | PMID:38483510 | PMID:39147115 |
NTHL1 (Homo sapiens - human) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nthl1 (Mus musculus - house mouse) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nthl1 (Rattus norvegicus - Norway rat) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nthl1 (Chinchilla lanigera - long-tailed chinchilla) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NTHL1 (Pan paniscus - bonobo/pygmy chimpanzee) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NTHL1 (Canis lupus familiaris - dog) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nthl1 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NTHL1 (Sus scrofa - pig) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NTHL1 (Chlorocebus sabaeus - green monkey) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nthl1 (Heterocephalus glaber - naked mole-rat) |
|
.
Variants in NTHL1
1355 total Variants |
Name | Type | Condition(s) | Position(s) | Clinical significance |
NM_002528.7(NTHL1):c.476C>G (p.Thr159Arg) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002348695]|not provided [RCV001211985] | Chr16:2044679 [GRCh38] Chr16:2094680 [GRCh37] Chr16:16p13.3 |
uncertain significance |
GRCh38/hg38 16p13.3(chr16:2046988-2060016)x3 | copy number gain | See cases [RCV000050702] | Chr16:2046988..2060016 [GRCh38] Chr16:2096989..2110017 [GRCh37] Chr16:2036990..2050018 [NCBI36] Chr16:16p13.3 |
uncertain significance |
GRCh38/hg38 16p13.3-13.13(chr16:23141-11296695)x3 | copy number gain | See cases [RCV000052367] | Chr16:23141..11296695 [GRCh38] Chr16:73141..11390552 [GRCh37] Chr16:13141..11298053 [NCBI36] Chr16:16p13.3-13.13 |
pathogenic |
GRCh38/hg38 16p13.3(chr16:29941-2560460)x3 | copy number gain | See cases [RCV000052368] | Chr16:29941..2560460 [GRCh38] Chr16:79941..2610461 [GRCh37] Chr16:19941..2550462 [NCBI36] Chr16:16p13.3 |
pathogenic |
GRCh38/hg38 16p13.3(chr16:46766-3214623)x3 | copy number gain | See cases [RCV000052370] | Chr16:46766..3214623 [GRCh38] Chr16:96766..3264623 [GRCh37] Chr16:36766..3204624 [NCBI36] Chr16:16p13.3 |
pathogenic |
GRCh38/hg38 16p13.3(chr16:1221651-2233773)x3 | copy number gain | See cases [RCV000052373] | Chr16:1221651..2233773 [GRCh38] Chr16:1271651..2283774 [GRCh37] Chr16:1211652..2223775 [NCBI36] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.203del (p.Gly68fs) | deletion | Familial adenomatous polyposis 3 [RCV003458204]|Hereditary cancer-predisposing syndrome [RCV004026006]|not provided [RCV000657475] | Chr16:2046279 [GRCh38] Chr16:2096280 [GRCh37] Chr16:16p13.3 |
pathogenic|likely pathogenic |
NM_002528.7(NTHL1):c.795del (p.Glu265fs) | deletion | Familial adenomatous polyposis 3 [RCV003458205]|Hereditary cancer-predisposing syndrome [RCV002424557]|not provided [RCV000657491] | Chr16:2040044 [GRCh38] Chr16:2090045 [GRCh37] Chr16:16p13.3 |
likely pathogenic |
NM_002528.7(NTHL1):c.661G>A (p.Ala221Thr) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV001292862]|Hereditary cancer-predisposing syndrome [RCV002366111] | Chr16:2043591 [GRCh38] Chr16:2093592 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.525+3G>T | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002350551]|not provided [RCV001303618] | Chr16:2044627 [GRCh38] Chr16:2094628 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.526-3C>T | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002256733]|not provided [RCV001303110] | Chr16:2043729 [GRCh38] Chr16:2093730 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.-15C>T | single nucleotide variant | Familial adenomatous polyposis 3 [RCV004570847]|Hereditary cancer-predisposing syndrome [RCV002431983]|not provided [RCV001348752] | Chr16:2047838 [GRCh38] Chr16:2097839 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.244C>T (p.Gln82Ter) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV000172911]|Hereditary cancer-predisposing syndrome [RCV000850062]|NTHL1-related disorder [RCV003416065]|not provided [RCV000657657] | Chr16:2046238 [GRCh38] Chr16:2096239 [GRCh37] Chr16:16p13.3 |
pathogenic|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
GRCh38/hg38 16p13.3-13.13(chr16:46766-11525516)x3 | copy number gain | See cases [RCV000133780] | Chr16:46766..11525516 [GRCh38] Chr16:96766..11619372 [GRCh37] Chr16:36766..11526873 [NCBI36] Chr16:16p13.3-13.13 |
pathogenic |
GRCh38/hg38 16p13.3(chr16:1850978-2116369)x3 | copy number gain | See cases [RCV000135695] | Chr16:1850978..2116369 [GRCh38] Chr16:1900979..2166370 [GRCh37] Chr16:1840980..2106371 [NCBI36] Chr16:16p13.3 |
uncertain significance |
GRCh38/hg38 16p13.3(chr16:46766-4247185)x3 | copy number gain | See cases [RCV000136687] | Chr16:46766..4247185 [GRCh38] Chr16:96766..4297186 [GRCh37] Chr16:36766..4237187 [NCBI36] Chr16:16p13.3 |
pathogenic |
GRCh38/hg38 16p13.3-13.12(chr16:43732-13326806)x3 | copy number gain | See cases [RCV000139166] | Chr16:43732..13326806 [GRCh38] Chr16:93732..13420663 [GRCh37] Chr16:33732..13328164 [NCBI36] Chr16:16p13.3-13.12 |
pathogenic |
GRCh38/hg38 16p13.3(chr16:2025885-2088686)x1 | copy number loss | See cases [RCV000140857] | Chr16:2025885..2088686 [GRCh38] Chr16:2075886..2138687 [GRCh37] Chr16:2015887..2078688 [NCBI36] Chr16:16p13.3 |
pathogenic |
GRCh38/hg38 16p13.3-13.11(chr16:666662-15743104)x3 | copy number gain | See cases [RCV000143710] | Chr16:666662..15743104 [GRCh38] Chr16:716662..15836961 [GRCh37] Chr16:656663..15744462 [NCBI36] Chr16:16p13.3-13.11 |
pathogenic |
NM_002528.7(NTHL1):c.685+1G>A | single nucleotide variant | Familial adenomatous polyposis 3 [RCV000202319]|Hereditary cancer-predisposing syndrome [RCV003352802]|not provided [RCV000807122] | Chr16:2043566 [GRCh38] Chr16:2093567 [GRCh37] Chr16:16p13.3 |
pathogenic|likely pathogenic |
GRCh37/hg19 16p13.3-11.2(chr16:102839-28327676)x3 | copy number gain | See cases [RCV000203445] | Chr16:102839..28327676 [GRCh37] Chr16:16p13.3-11.2 |
pathogenic |
GRCh37/hg19 16p13.3-11.2(chr16:1279324-31926800)x3 | copy number gain | Breast ductal adenocarcinoma [RCV000207053] | Chr16:1279324..31926800 [GRCh37] Chr16:16p13.3-11.2 |
uncertain significance |
GRCh37/hg19 16p13.3-12.3(chr16:1274615-19073133)x3 | copy number gain | Breast ductal adenocarcinoma [RCV000207326] | Chr16:1274615..19073133 [GRCh37] Chr16:16p13.3-12.3 |
uncertain significance |
NM_002528.7(NTHL1):c.503T>C (p.Ile168Thr) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV000767388]|Hereditary cancer-predisposing syndrome [RCV001023853]|NTHL1-related disorder [RCV003953261]|not provided [RCV000896408]|not specified [RCV001816746] | Chr16:2044652 [GRCh38] Chr16:2094653 [GRCh37] Chr16:16p13.3 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
GRCh37/hg19 16p13.3(chr16:2096989-2135026)x1 | copy number loss | See cases [RCV000239976] | Chr16:2096989..2135026 [GRCh37] Chr16:16p13.3 |
pathogenic |
GRCh37/hg19 16p13.3(chr16:2096989-2126539)x1 | copy number loss | See cases [RCV000239844] | Chr16:2096989..2126539 [GRCh37] Chr16:16p13.3 |
pathogenic |
GRCh37/hg19 16p13.3(chr16:2096989-2100568)x1 | copy number loss | See cases [RCV000240588] | Chr16:2096989..2100568 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.274C>T (p.Arg92Cys) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV000765258]|Hereditary cancer-predisposing syndrome [RCV001017807]|NTHL1-related disorder [RCV003945401]|not provided [RCV000592496]|not specified [RCV001800825] | Chr16:2046208 [GRCh38] Chr16:2096209 [GRCh37] Chr16:16p13.3 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_002528.7(NTHL1):c.792-7C>A | single nucleotide variant | not provided [RCV000806092] | Chr16:2040054 [GRCh38] Chr16:2090055 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_002528.7(NTHL1):c.620C>T (p.Pro207Leu) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003325216]|Hereditary cancer-predisposing syndrome [RCV001025278]|not provided [RCV000806170] | Chr16:2043632 [GRCh38] Chr16:2093633 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.184G>A (p.Gly62Ser) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001014395]|not provided [RCV000806180] | Chr16:2046298 [GRCh38] Chr16:2096299 [GRCh37] Chr16:16p13.3 |
uncertain significance |
GRCh37/hg19 16p13.3-q24.3(chr16:69193-90274381)x3 | copy number gain | See cases [RCV000446684] | Chr16:69193..90274381 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
GRCh37/hg19 16p13.3-13.2(chr16:78801-9169448) | copy number gain | See cases [RCV000446555] | Chr16:78801..9169448 [GRCh37] Chr16:16p13.3-13.2 |
pathogenic |
GRCh37/hg19 16p13.3(chr16:97133-5122974)x3 | copy number gain | See cases [RCV000445663] | Chr16:97133..5122974 [GRCh37] Chr16:16p13.3 |
pathogenic |
GRCh37/hg19 16p13.3(chr16:643377-3125125)x3 | copy number gain | See cases [RCV000510815] | Chr16:643377..3125125 [GRCh37] Chr16:16p13.3 |
uncertain significance |
maternal UPD(16p) | complex | Hemimegalencephaly [RCV000494707] | Chr16:1280042..33710558 [GRCh37] Chr16:16p13.3-11.2 |
pathogenic |
NM_002528.7(NTHL1):c.843C>T (p.Thr281=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003293265] | Chr16:2039996 [GRCh38] Chr16:2089997 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.16G>T (p.Ala6Ser) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003302009] | Chr16:2047808 [GRCh38] Chr16:2097809 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.345C>T (p.Ala115=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001020914]|not provided [RCV000935933]|not specified [RCV002465737] | Chr16:2046137 [GRCh38] Chr16:2096138 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.832G>A (p.Gly278Ser) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV000767389]|Hereditary cancer-predisposing syndrome [RCV001018027]|not provided [RCV000816265] | Chr16:2040007 [GRCh38] Chr16:2090008 [GRCh37] Chr16:16p13.3 |
uncertain significance |
GRCh37/hg19 16p13.3-13.2(chr16:85880-9883129)x3 | copy number gain | See cases [RCV000510698] | Chr16:85880..9883129 [GRCh37] Chr16:16p13.3-13.2 |
pathogenic |
NM_002528.7(NTHL1):c.437T>G (p.Leu146Arg) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003302011] | Chr16:2044718 [GRCh38] Chr16:2094719 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.853G>C (p.Val285Leu) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003302012] | Chr16:2039986 [GRCh38] Chr16:2089987 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.469C>T (p.Leu157=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003302016] | Chr16:2044686 [GRCh38] Chr16:2094687 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.519C>G (p.Phe173Leu) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003293267] | Chr16:2044636 [GRCh38] Chr16:2094637 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.545dup (p.Gln183fs) | duplication | Familial adenomatous polyposis 1 [RCV004720390]|Hereditary cancer-predisposing syndrome [RCV003293268] | Chr16:2043706..2043707 [GRCh38] Chr16:2093707..2093708 [GRCh37] Chr16:16p13.3 |
likely pathogenic|uncertain significance |
GRCh37/hg19 16p13.3-12.3(chr16:85880-19806921)x3 | copy number gain | See cases [RCV000512194] | Chr16:85880..19806921 [GRCh37] Chr16:16p13.3-12.3 |
pathogenic |
NM_002528.7(NTHL1):c.420G>A (p.Ala140=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002256412]|not provided [RCV000935721] | Chr16:2044735 [GRCh38] Chr16:2094736 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.526-11_526-10del | deletion | Hereditary cancer-predisposing syndrome [RCV002256411]|not provided [RCV000915882]|not specified [RCV004596302] | Chr16:2043736..2043737 [GRCh38] Chr16:2093737..2093738 [GRCh37] Chr16:16p13.3 |
likely benign|conflicting interpretations of pathogenicity |
NM_002528.7(NTHL1):c.444G>A (p.Ala148=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001022899]|NTHL1-related disorder [RCV003962814]|not provided [RCV000935646] | Chr16:2044711 [GRCh38] Chr16:2094712 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.516T>G (p.Gly172=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002343151]|not provided [RCV002066639]|not specified [RCV000613064] | Chr16:2044639 [GRCh38] Chr16:2094640 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.115+6G>A | single nucleotide variant | not provided [RCV000812618]|not specified [RCV000610479] | Chr16:2047703 [GRCh38] Chr16:2097704 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_002528.7(NTHL1):c.610G>C (p.Val204Leu) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003296429] | Chr16:2043642 [GRCh38] Chr16:2093643 [GRCh37] Chr16:16p13.3 |
uncertain significance |
GRCh37/hg19 16p13.3-12.2(chr16:85880-22442007)x3 | copy number gain | See cases [RCV000511360] | Chr16:85880..22442007 [GRCh37] Chr16:16p13.3-12.2 |
pathogenic |
NM_002528.7(NTHL1):c.613G>T (p.Ala205Ser) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003293269] | Chr16:2043639 [GRCh38] Chr16:2093640 [GRCh37] Chr16:16p13.3 |
uncertain significance |
GRCh37/hg19 16p13.3-q24.3(chr16:85881-90155062) | copy number gain | See cases [RCV000511296] | Chr16:85881..90155062 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
GRCh37/hg19 16p13.3-q24.3(chr16:85881-90155062)x3 | copy number gain | See cases [RCV000512138] | Chr16:85881..90155062 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
NM_002528.7(NTHL1):c.211dup (p.Ala71fs) | duplication | Familial adenomatous polyposis 3 [RCV001310141]|Hereditary cancer-predisposing syndrome [RCV002256456]|not provided [RCV000657485] | Chr16:2046270..2046271 [GRCh38] Chr16:2096271..2096272 [GRCh37] Chr16:16p13.3 |
pathogenic|likely pathogenic |
GRCh37/hg19 16p13.3(chr16:85880-3216551)x3 | copy number gain | not provided [RCV000683742] | Chr16:85880..3216551 [GRCh37] Chr16:16p13.3 |
pathogenic |
GRCh37/hg19 16p13.3(chr16:1505184-4415346)x3 | copy number gain | not provided [RCV000683745] | Chr16:1505184..4415346 [GRCh37] Chr16:16p13.3 |
pathogenic |
GRCh37/hg19 16p13.3(chr16:1734363-2285561)x1 | copy number loss | not provided [RCV000683746] | Chr16:1734363..2285561 [GRCh37] Chr16:16p13.3 |
pathogenic |
GRCh37/hg19 16p13.3-13.13(chr16:85880-11209288)x3 | copy number gain | not provided [RCV000683743] | Chr16:85880..11209288 [GRCh37] Chr16:16p13.3-13.13 |
pathogenic |
Single allele | inversion | Hereditary cancer-predisposing syndrome [RCV000850149] | Chr16:1566500..2119769 [GRCh37] Chr16:16p13.3 |
uncertain significance |
GRCh37/hg19 16p13.3-q24.3(chr16:88165-90163275)x3 | copy number gain | not provided [RCV000738917] | Chr16:88165..90163275 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
GRCh37/hg19 16p13.3-q24.3(chr16:88165-90274695)x3 | copy number gain | not provided [RCV000738918] | Chr16:88165..90274695 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
GRCh37/hg19 16p13.3-q24.3(chr16:61451-90294632)x3 | copy number gain | not provided [RCV000738915] | Chr16:61451..90294632 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
GRCh37/hg19 16p13.3(chr16:1807896-2311160)x3 | copy number gain | not provided [RCV000738986] | Chr16:1807896..2311160 [GRCh37] Chr16:16p13.3 |
benign |
GRCh37/hg19 16p13.3(chr16:1813658-2319717)x3 | copy number gain | not provided [RCV000738989] | Chr16:1813658..2319717 [GRCh37] Chr16:16p13.3 |
benign |
GRCh37/hg19 16p13.3(chr16:2036937-2093576)x1 | copy number loss | not provided [RCV000751522] | Chr16:2036937..2093576 [GRCh37] Chr16:16p13.3 |
benign |
NM_002528.7(NTHL1):c.115+10C>T | single nucleotide variant | not provided [RCV000940213] | Chr16:2047699 [GRCh38] Chr16:2097700 [GRCh37] Chr16:16p13.3 |
likely benign|conflicting interpretations of pathogenicity |
NM_002528.7(NTHL1):c.183G>A (p.Glu61=) | single nucleotide variant | not provided [RCV000938011] | Chr16:2046299 [GRCh38] Chr16:2096300 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.30C>G (p.Thr10=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002346122]|not provided [RCV000936067] | Chr16:2047794 [GRCh38] Chr16:2097795 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.450C>T (p.Gly150=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002336970]|not provided [RCV000939652] | Chr16:2044705 [GRCh38] Chr16:2094706 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.486C>T (p.Ala162=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001023558]|not provided [RCV000936454] | Chr16:2044669 [GRCh38] Chr16:2094670 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.835C>T (p.Gln279Ter) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV001535451]|Hereditary cancer-predisposing syndrome [RCV001018044]|NTHL1-related disorder [RCV004751695]|not provided [RCV000760534] | Chr16:2040004 [GRCh38] Chr16:2090005 [GRCh37] Chr16:16p13.3 |
pathogenic|likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance|not provided |
NM_002528.7(NTHL1):c.644A>G (p.His215Arg) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003467810]|Hereditary cancer-predisposing syndrome [RCV002365736]|not provided [RCV001060886] | Chr16:2043608 [GRCh38] Chr16:2093609 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.88C>G (p.Pro30Ala) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002320298]|not provided [RCV001054452] | Chr16:2047736 [GRCh38] Chr16:2097737 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.349C>A (p.Pro117Thr) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV001789786]|Hereditary cancer-predisposing syndrome [RCV002365709]|not provided [RCV001055409]|not specified [RCV002268420] | Chr16:2046133 [GRCh38] Chr16:2096134 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.689_691del (p.Val230del) | deletion | not provided [RCV001056452] | Chr16:2040233..2040235 [GRCh38] Chr16:2090234..2090236 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.41G>A (p.Ser14Asn) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002374937]|not provided [RCV001057848]|not specified [RCV003321791] | Chr16:2047783 [GRCh38] Chr16:2097784 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.298G>A (p.Ala100Thr) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003467788]|Hereditary cancer-predisposing syndrome [RCV002258117]|not provided [RCV001058068] | Chr16:2046184 [GRCh38] Chr16:2096185 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.116-9dup | duplication | Hereditary cancer-predisposing syndrome [RCV002391035]|NTHL1-related disorder [RCV004751847]|not provided [RCV000982549] | Chr16:2046370..2046371 [GRCh38] Chr16:2096371..2096372 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_002528.7(NTHL1):c.705C>T (p.His235=) | single nucleotide variant | not provided [RCV000944892] | Chr16:2040219 [GRCh38] Chr16:2090220 [GRCh37] Chr16:16p13.3 |
likely benign|conflicting interpretations of pathogenicity |
NM_002528.7(NTHL1):c.564G>C (p.Leu188=) | single nucleotide variant | not provided [RCV000944914] | Chr16:2043688 [GRCh38] Chr16:2093689 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.681C>T (p.Gly227=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002363457]|not provided [RCV000944989] | Chr16:2043571 [GRCh38] Chr16:2093572 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_002528.7(NTHL1):c.54G>C (p.Gly18=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002409308]|not provided [RCV000983103] | Chr16:2047770 [GRCh38] Chr16:2097771 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.297T>C (p.Asp99=) | single nucleotide variant | not provided [RCV000983170] | Chr16:2046185 [GRCh38] Chr16:2096186 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.744C>G (p.Thr248=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002400153]|not provided [RCV000982525] | Chr16:2040180 [GRCh38] Chr16:2090181 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.15C>T (p.Ser5=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV004639420]|not provided [RCV000975836] | Chr16:2047809 [GRCh38] Chr16:2097810 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.375G>A (p.Leu125=) | single nucleotide variant | not provided [RCV000943683] | Chr16:2044780 [GRCh38] Chr16:2094781 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.777G>A (p.Glu259=) | single nucleotide variant | not provided [RCV000976245] | Chr16:2040147 [GRCh38] Chr16:2090148 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.685+9A>G | single nucleotide variant | not provided [RCV000976305] | Chr16:2043558 [GRCh38] Chr16:2093559 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.366C>T (p.Tyr122=) | single nucleotide variant | not provided [RCV000944234] | Chr16:2044789 [GRCh38] Chr16:2094790 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.60G>T (p.Gly20=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002445135]|not provided [RCV000980995] | Chr16:2047764 [GRCh38] Chr16:2097765 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.526-10T>C | single nucleotide variant | not provided [RCV000944541] | Chr16:2043736 [GRCh38] Chr16:2093737 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.621G>A (p.Pro207=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002258046]|NTHL1-related disorder [RCV004751821]|not provided [RCV000925466]|not specified [RCV002268355] | Chr16:2043631 [GRCh38] Chr16:2093632 [GRCh37] Chr16:16p13.3 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_002528.7(NTHL1):c.621G>C (p.Pro207=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001025292]|not provided [RCV000983636] | Chr16:2043631 [GRCh38] Chr16:2093632 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.93C>A (p.Leu31=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002336984]|not provided [RCV000942516] | Chr16:2047731 [GRCh38] Chr16:2097732 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.336C>G (p.Asp112Glu) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002451310]|not provided [RCV001071197] | Chr16:2046146 [GRCh38] Chr16:2096147 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.10:g.(?_2039924)_(2048065_?)dup | duplication | Tuberous sclerosis 2 [RCV001364791]|not provided [RCV001033362] | Chr16:2089925..2098066 [GRCh37] Chr16:16p13.3 |
uncertain significance|no classifications from unflagged records |
NM_002528.7(NTHL1):c.32G>T (p.Arg11Leu) | single nucleotide variant | not provided [RCV001037470] | Chr16:2047792 [GRCh38] Chr16:2097793 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.288_290del (p.Asn96del) | deletion | Hereditary cancer-predisposing syndrome [RCV004031332]|not provided [RCV001043838] | Chr16:2046192..2046194 [GRCh38] Chr16:2096193..2096195 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.187T>G (p.Ser63Ala) | single nucleotide variant | not provided [RCV001071933] | Chr16:2046295 [GRCh38] Chr16:2096296 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.262C>A (p.Leu88Met) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002436601]|not provided [RCV001050733] | Chr16:2046220 [GRCh38] Chr16:2096221 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.526-10T>A | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002255607]|not provided [RCV001039767] | Chr16:2043736 [GRCh38] Chr16:2093737 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.574T>G (p.Tyr192Asp) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002355039]|NTHL1-related disorder [RCV004553594]|not provided [RCV001053550] | Chr16:2043678 [GRCh38] Chr16:2093679 [GRCh37] Chr16:16p13.3 |
uncertain significance|not provided |
NM_002528.7(NTHL1):c.631C>T (p.Pro211Ser) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002363570]|not provided [RCV001040177] | Chr16:2043621 [GRCh38] Chr16:2093622 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.532G>T (p.Val178Leu) | single nucleotide variant | not provided [RCV001040217] | Chr16:2043720 [GRCh38] Chr16:2093721 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.410A>T (p.Gln137Leu) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003467723]|not provided [RCV001040568] | Chr16:2044745 [GRCh38] Chr16:2094746 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.64C>T (p.Arg22Trp) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002374965]|not provided [RCV001064256] | Chr16:2047760 [GRCh38] Chr16:2097761 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.232G>A (p.Val78Ile) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003160560]|not provided [RCV001068251] | Chr16:2046250 [GRCh38] Chr16:2096251 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.680G>C (p.Gly227Ala) | single nucleotide variant | not provided [RCV001061555] | Chr16:2043572 [GRCh38] Chr16:2093573 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.304G>A (p.Val102Met) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002256650]|not provided [RCV001041935] | Chr16:2046178 [GRCh38] Chr16:2096179 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.569A>T (p.Gln190Leu) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002355016]|not provided [RCV001046371] | Chr16:2043683 [GRCh38] Chr16:2093684 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.416CGG[1] (p.Ala140del) | microsatellite | Hereditary cancer-predisposing syndrome [RCV002327360]|not provided [RCV001069016] | Chr16:2044734..2044736 [GRCh38] Chr16:2094735..2094737 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.380C>T (p.Ser127Leu) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002320253]|not provided [RCV001042202] | Chr16:2044775 [GRCh38] Chr16:2094776 [GRCh37] Chr16:16p13.3 |
uncertain significance |
GRCh37/hg19 16p13.3(chr16:109978-4316797) | copy number gain | Chromosome 16p13.3 duplication syndrome [RCV000767731] | Chr16:109978..4316797 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.319A>C (p.Thr107Pro) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002451195]|not provided [RCV001048419] | Chr16:2046163 [GRCh38] Chr16:2096164 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.855_856delinsTT (p.His286Tyr) | indel | Hereditary cancer-predisposing syndrome [RCV003160201]|not provided [RCV001035080] | Chr16:2039983..2039984 [GRCh38] Chr16:2089984..2089985 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.650_653dup (p.Met218fs) | duplication | Hereditary cancer-predisposing syndrome [RCV004649425]|not provided [RCV001048612] | Chr16:2043598..2043599 [GRCh38] Chr16:2093599..2093600 [GRCh37] Chr16:16p13.3 |
pathogenic|uncertain significance |
NM_002528.7(NTHL1):c.596C>G (p.Ser199Cys) | single nucleotide variant | not provided [RCV001071762] | Chr16:2043656 [GRCh38] Chr16:2093657 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.10:g.(?_2039924)_(2093096_?)del | deletion | Tuberous sclerosis 2 [RCV001386091]|not provided [RCV001032167] | Chr16:2089925..2143097 [GRCh37] Chr16:16p13.3 |
pathogenic|no classifications from unflagged records |
NC_000016.10:g.(?_2039924)_(2082514_?)dup | duplication | Tuberous sclerosis 2 [RCV001364792]|not provided [RCV001033192] | Chr16:2089925..2132515 [GRCh37] Chr16:16p13.3 |
uncertain significance|no classifications from unflagged records |
NM_002528.7(NTHL1):c.68G>T (p.Gly23Val) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002374897]|not provided [RCV001049217] | Chr16:2047756 [GRCh38] Chr16:2097757 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.792-3C>G | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002416375]|not provided [RCV001049414] | Chr16:2040050 [GRCh38] Chr16:2090051 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.176C>T (p.Ala59Val) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV004570279]|Hereditary cancer-predisposing syndrome [RCV002418550]|not provided [RCV001066597] | Chr16:2046306 [GRCh38] Chr16:2096307 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.9:g.(?_1203718)_(2185710_?)del | deletion | Tuberous sclerosis 2 [RCV001033886] | Chr16:1203718..2185710 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.313C>G (p.Leu105Val) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV004030757]|not provided [RCV001070608] | Chr16:2046169 [GRCh38] Chr16:2096170 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.859C>T (p.Pro287Ser) | single nucleotide variant | not provided [RCV001049579] | Chr16:2039980 [GRCh38] Chr16:2089981 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.344C>A (p.Ala115Asp) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV004569638]|Hereditary cancer-predisposing syndrome [RCV002352388]|not provided [RCV000806918] | Chr16:2046138 [GRCh38] Chr16:2096139 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.805G>A (p.Glu269Lys) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV004569495]|Hereditary cancer-predisposing syndrome [RCV001027375]|not provided [RCV000791544] | Chr16:2040034 [GRCh38] Chr16:2090035 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.359G>A (p.Arg120His) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001021267]|not provided [RCV000791743] | Chr16:2044796 [GRCh38] Chr16:2094797 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.782G>A (p.Trp261Ter) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV001784408]|Hereditary cancer-predisposing syndrome [RCV001027136]|not provided [RCV000792395] | Chr16:2040142 [GRCh38] Chr16:2090143 [GRCh37] Chr16:16p13.3 |
pathogenic|likely pathogenic|uncertain significance |
NM_002528.7(NTHL1):c.59G>A (p.Gly20Glu) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002440734]|not provided [RCV000808918] | Chr16:2047765 [GRCh38] Chr16:2097766 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.354+4G>T | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001021121]|NTHL1-related disorder [RCV003892739]|not provided [RCV000813619]|not specified [RCV002465788] | Chr16:2046124 [GRCh38] Chr16:2096125 [GRCh37] Chr16:16p13.3 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_002528.7(NTHL1):c.576C>T (p.Tyr192=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001024803]|NTHL1-related disorder [RCV003950848]|not provided [RCV000917526]|not specified [RCV004596372] | Chr16:2043676 [GRCh38] Chr16:2093677 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.69G>T (p.Gly23=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002372625]|not provided [RCV000941444] | Chr16:2047755 [GRCh38] Chr16:2097756 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.116-9T>C | single nucleotide variant | not provided [RCV000939709] | Chr16:2046375 [GRCh38] Chr16:2096376 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.6C>T (p.Thr2=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003363018]|not provided [RCV000933087] | Chr16:2047818 [GRCh38] Chr16:2097819 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.870C>T (p.His290=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002256624]|not provided [RCV000938650] | Chr16:2039969 [GRCh38] Chr16:2089970 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.100A>C (p.Arg34=) | single nucleotide variant | not provided [RCV000979110] | Chr16:2047724 [GRCh38] Chr16:2097725 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.66G>C (p.Arg22=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002372599]|not provided [RCV000933145] | Chr16:2047758 [GRCh38] Chr16:2097759 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.765C>T (p.Arg255=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002256625]|not provided [RCV000938959]|not specified [RCV003321767] | Chr16:2040159 [GRCh38] Chr16:2090160 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.-1C>T | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002454154]|not provided [RCV000940328]|not specified [RCV003320223] | Chr16:2047824 [GRCh38] Chr16:2097825 [GRCh37] Chr16:16p13.3 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_002528.7(NTHL1):c.432G>A (p.Gln144=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002337025]|not provided [RCV000979496] | Chr16:2044723 [GRCh38] Chr16:2094724 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.141G>A (p.Val47=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002400009]|not provided [RCV000918526] | Chr16:2046341 [GRCh38] Chr16:2096342 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.115+9G>A | single nucleotide variant | Familial adenomatous polyposis 3 [RCV002502883]|not provided [RCV000941810] | Chr16:2047700 [GRCh38] Chr16:2097701 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.603C>T (p.Ala201=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002363439]|not provided [RCV000940733] | Chr16:2043649 [GRCh38] Chr16:2093650 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.453G>A (p.Leu151=) | single nucleotide variant | not provided [RCV000937067] | Chr16:2044702 [GRCh38] Chr16:2094703 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.348C>A (p.Pro116=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001020986]|NTHL1-related disorder [RCV003895699]|not provided [RCV000937374] | Chr16:2046134 [GRCh38] Chr16:2096135 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.72T>C (p.Cys24=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003169419]|not provided [RCV000939707] | Chr16:2047752 [GRCh38] Chr16:2097753 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.489G>A (p.Thr163=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001023600]|NTHL1-related disorder [RCV003925836]|not provided [RCV000941155] | Chr16:2044666 [GRCh38] Chr16:2094667 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.6C>G (p.Thr2=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002320137]|not provided [RCV000939146] | Chr16:2047818 [GRCh38] Chr16:2097819 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.318G>A (p.Gly106=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV004029713]|not provided [RCV000941318] | Chr16:2046164 [GRCh38] Chr16:2096165 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.897G>A (p.Pro299=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001019026]|not provided [RCV000936184] | Chr16:2039942 [GRCh38] Chr16:2089943 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.138C>T (p.Pro46=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001012491]|not provided [RCV000936329]|not specified [RCV002268366] | Chr16:2046344 [GRCh38] Chr16:2096345 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.556G>T (p.Ala186Ser) | single nucleotide variant | not provided [RCV002284654] | Chr16:2043696 [GRCh38] Chr16:2093697 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.43C>G (p.Leu15Val) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV004569589]|Hereditary cancer-predisposing syndrome [RCV002360957]|not provided [RCV000802537] | Chr16:2047781 [GRCh38] Chr16:2097782 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.897_904del (p.Ala300fs) | deletion | not provided [RCV000813557] | Chr16:2039935..2039942 [GRCh38] Chr16:2089936..2089943 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.752C>T (p.Pro251Leu) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV004569509]|Hereditary cancer-predisposing syndrome [RCV001026794]|not provided [RCV000792810] | Chr16:2040172 [GRCh38] Chr16:2090173 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.9:g.(?_624055)_(2115656_?)del | deletion | Tuberous sclerosis 2 [RCV000811345] | Chr16:624055..2115656 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.2T>A (p.Met1Lys) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV004028775]|not provided [RCV000812615] | Chr16:2047822 [GRCh38] Chr16:2097823 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.25C>G (p.Leu9Val) | single nucleotide variant | not provided [RCV000802597] | Chr16:2047799 [GRCh38] Chr16:2097800 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.188C>T (p.Ser63Leu) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001014556]|not provided [RCV000822625] | Chr16:2046294 [GRCh38] Chr16:2096295 [GRCh37] Chr16:16p13.3 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_002528.7(NTHL1):c.145C>T (p.Arg49Cys) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003467434]|Hereditary cancer-predisposing syndrome [RCV002397662]|NTHL1-related disorder [RCV004751723]|not provided [RCV000809525] | Chr16:2046337 [GRCh38] Chr16:2096338 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_002528.7(NTHL1):c.366C>G (p.Tyr122Ter) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003458208]|Hereditary cancer-predisposing syndrome [RCV002352346]|not provided [RCV000799280] | Chr16:2044789 [GRCh38] Chr16:2094790 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.31C>G (p.Arg11Gly) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002345886]|not provided [RCV000819128] | Chr16:2047793 [GRCh38] Chr16:2097794 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.116-37T>C | single nucleotide variant | not provided [RCV000839416]|not specified [RCV002268336] | Chr16:2046403 [GRCh38] Chr16:2096404 [GRCh37] Chr16:16p13.3 |
benign|likely benign |
NM_002528.7(NTHL1):c.637A>G (p.Met213Val) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003467403]|Hereditary cancer-predisposing syndrome [RCV002360970]|not provided [RCV000804564] | Chr16:2043615 [GRCh38] Chr16:2093616 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.525+131C>T | single nucleotide variant | not provided [RCV000839474] | Chr16:2044499 [GRCh38] Chr16:2094500 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.792-6C>G | single nucleotide variant | not provided [RCV000804576] | Chr16:2040053 [GRCh38] Chr16:2090054 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_002528.7(NTHL1):c.445C>T (p.Arg149Trp) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV001535743]|Hereditary cancer-predisposing syndrome [RCV001022917]|not provided [RCV000822885] | Chr16:2044710 [GRCh38] Chr16:2094711 [GRCh37] Chr16:16p13.3 |
uncertain significance|not provided |
NM_002528.7(NTHL1):c.693C>A (p.Asp231Glu) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003467513]|Hereditary cancer-predisposing syndrome [RCV003307559]|not provided [RCV000822923] | Chr16:2040231 [GRCh38] Chr16:2090232 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.9C>T (p.Ala3=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002453912]|NTHL1-related disorder [RCV003892761]|not provided [RCV000828130]|not specified [RCV002465790] | Chr16:2047815 [GRCh38] Chr16:2097816 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.614C>T (p.Ala205Val) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003467337]|Hereditary cancer-predisposing syndrome [RCV001025209]|NTHL1-related disorder [RCV003411745]|not provided [RCV000793824]|not specified [RCV002465780] | Chr16:2043638 [GRCh38] Chr16:2093639 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.62C>A (p.Pro21Gln) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV004649338]|not provided [RCV000813233] | Chr16:2047762 [GRCh38] Chr16:2097763 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.746A>G (p.Lys249Arg) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003153857]|Hereditary cancer-predisposing syndrome [RCV001026740]|not provided [RCV000815936]|not specified [RCV002268308] | Chr16:2040178 [GRCh38] Chr16:2090179 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.808A>G (p.Ile270Val) | single nucleotide variant | not provided [RCV000821108] | Chr16:2040031 [GRCh38] Chr16:2090032 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.424G>A (p.Ala142Thr) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV004569779]|Hereditary cancer-predisposing syndrome [RCV002332719]|not provided [RCV000823171] | Chr16:2044731 [GRCh38] Chr16:2094732 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.764G>A (p.Arg255His) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003467378]|Hereditary cancer-predisposing syndrome [RCV001026916]|not provided [RCV000799534] | Chr16:2040160 [GRCh38] Chr16:2090161 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.882C>G (p.Asn294Lys) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002370117]|not provided [RCV000801236] | Chr16:2039957 [GRCh38] Chr16:2089958 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.680G>A (p.Gly227Asp) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV001535682]|Hereditary cancer-predisposing syndrome [RCV001025970]|not provided [RCV000804775]|not specified [RCV001816871] | Chr16:2043572 [GRCh38] Chr16:2093573 [GRCh37] Chr16:16p13.3 |
uncertain significance|not provided |
NM_002528.7(NTHL1):c.842C>T (p.Thr281Ile) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002442755]|not provided [RCV000821199] | Chr16:2039997 [GRCh38] Chr16:2089998 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.863G>A (p.Arg288His) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002442698]|not provided [RCV000807053] | Chr16:2039976 [GRCh38] Chr16:2089977 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.791+5G>A | single nucleotide variant | not provided [RCV000794011] | Chr16:2040128 [GRCh38] Chr16:2090129 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.366C>A (p.Tyr122Ter) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003458206]|Hereditary cancer-predisposing syndrome [RCV001021416]|not provided [RCV000798528] | Chr16:2044789 [GRCh38] Chr16:2094790 [GRCh37] Chr16:16p13.3 |
pathogenic|likely pathogenic |
NM_002528.7(NTHL1):c.613G>A (p.Ala205Thr) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003461216]|Hereditary cancer-predisposing syndrome [RCV002352424]|not provided [RCV000813666] | Chr16:2043639 [GRCh38] Chr16:2093640 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_002528.7(NTHL1):c.282G>C (p.Met94Ile) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002442659]|not provided [RCV000801325] | Chr16:2046200 [GRCh38] Chr16:2096201 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.718A>G (p.Arg240Gly) | single nucleotide variant | not provided [RCV000804850] | Chr16:2040206 [GRCh38] Chr16:2090207 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.22A>C (p.Met8Leu) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003467419]|Hereditary cancer-predisposing syndrome [RCV002336647]|not provided [RCV000807336] | Chr16:2047802 [GRCh38] Chr16:2097803 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.409C>T (p.Gln137Ter) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003458212]|Hereditary cancer-predisposing syndrome [RCV002332652]|not provided [RCV000807474] | Chr16:2044746 [GRCh38] Chr16:2094747 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.355G>T (p.Val119Leu) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003467340]|Hereditary cancer-predisposing syndrome [RCV002352323]|not provided [RCV000794253] | Chr16:2044800 [GRCh38] Chr16:2094801 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_002528.7(NTHL1):c.172G>T (p.Val58Leu) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003483727]|Hereditary cancer-predisposing syndrome [RCV002422718]|not provided [RCV000797626] | Chr16:2046310 [GRCh38] Chr16:2096311 [GRCh37] Chr16:16p13.3 |
uncertain significance|not provided |
NM_002528.7(NTHL1):c.907G>C (p.Gly303Arg) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001019169]|not provided [RCV000823817] | Chr16:2039932 [GRCh38] Chr16:2089933 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NC_000016.10:g.2047846A>G | single nucleotide variant | not provided [RCV000793878] | Chr16:2047846 [GRCh38] Chr16:2097847 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.146G>A (p.Arg49His) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002257970]|not provided [RCV000806226] | Chr16:2046336 [GRCh38] Chr16:2096337 [GRCh37] Chr16:16p13.3 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_002528.7(NTHL1):c.433C>T (p.Arg145Ter) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003458209]|Hereditary cancer-predisposing syndrome [RCV002336609]|not provided [RCV000801523] | Chr16:2044722 [GRCh38] Chr16:2094723 [GRCh37] Chr16:16p13.3 |
pathogenic|likely pathogenic |
NM_002528.7(NTHL1):c.295G>T (p.Asp99Tyr) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV004569598]|Hereditary cancer-predisposing syndrome [RCV004028138]|not provided [RCV000803262] | Chr16:2046187 [GRCh38] Chr16:2096188 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.896C>T (p.Pro299Leu) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003467507]|Hereditary cancer-predisposing syndrome [RCV001019003]|not provided [RCV000821534] | Chr16:2039943 [GRCh38] Chr16:2089944 [GRCh37] Chr16:16p13.3 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_002528.7(NTHL1):c.672T>G (p.Thr224=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002363423]|not provided [RCV000937388] | Chr16:2043580 [GRCh38] Chr16:2093581 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.671C>T (p.Thr224Ile) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003467451]|Hereditary cancer-predisposing syndrome [RCV002363097]|not provided [RCV000811180] | Chr16:2043581 [GRCh38] Chr16:2093582 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.463A>G (p.Ser155Gly) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002336640]|not provided [RCV000806528] | Chr16:2044692 [GRCh38] Chr16:2094693 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.806A>T (p.Glu269Val) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003467477]|Hereditary cancer-predisposing syndrome [RCV002427016]|not provided [RCV000816420] | Chr16:2040033 [GRCh38] Chr16:2090034 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.281T>C (p.Met94Thr) | single nucleotide variant | not provided [RCV000819772] | Chr16:2046201 [GRCh38] Chr16:2096202 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.769G>C (p.Ala257Pro) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003467493]|Hereditary cancer-predisposing syndrome [RCV001026981]|not provided [RCV000819782] | Chr16:2040155 [GRCh38] Chr16:2090156 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.526-1G>A | single nucleotide variant | Familial adenomatous polyposis 3 [RCV002290473]|Hereditary cancer-predisposing syndrome [RCV001024197]|not provided [RCV000824366] | Chr16:2043727 [GRCh38] Chr16:2093728 [GRCh37] Chr16:16p13.3 |
pathogenic|likely pathogenic |
NM_002528.7(NTHL1):c.349C>G (p.Pro117Ala) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003467346]|Hereditary cancer-predisposing syndrome [RCV002343660]|not provided [RCV000795098] | Chr16:2046133 [GRCh38] Chr16:2096134 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.455C>G (p.Thr152Arg) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002336704]|not provided [RCV000819947] | Chr16:2044700 [GRCh38] Chr16:2094701 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.71G>A (p.Cys24Tyr) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001019545]|NTHL1-related disorder [RCV003413662]|not provided [RCV000824649] | Chr16:2047753 [GRCh38] Chr16:2097754 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_002528.7(NTHL1):c.455C>T (p.Thr152Met) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003461120]|Hereditary cancer-predisposing syndrome [RCV001023068]|NTHL1-related disorder [RCV003411759]|not provided [RCV000800146] | Chr16:2044700 [GRCh38] Chr16:2094701 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.551C>G (p.Thr184Ser) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV004569565]|Hereditary cancer-predisposing syndrome [RCV002345782]|not provided [RCV000800150] | Chr16:2043701 [GRCh38] Chr16:2093702 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.169C>T (p.Arg57Cys) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003483742]|Hereditary cancer-predisposing syndrome [RCV001013758]|not provided [RCV000820003] | Chr16:2046313 [GRCh38] Chr16:2096314 [GRCh37] Chr16:16p13.3 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance|not provided |
NM_002528.7(NTHL1):c.95G>A (p.Arg32Gln) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV004028719]|not provided [RCV000811166] | Chr16:2047729 [GRCh38] Chr16:2097730 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.-5C>G | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002259015]|not provided [RCV000791629] | Chr16:2047828 [GRCh38] Chr16:2097829 [GRCh37] Chr16:16p13.3 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_002528.7(NTHL1):c.170G>A (p.Arg57His) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001013720]|NTHL1-related disorder [RCV003411787]|not provided [RCV000808834] | Chr16:2046312 [GRCh38] Chr16:2096313 [GRCh37] Chr16:16p13.3 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_002528.7(NTHL1):c.116-1G>A | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003458213]|Hereditary cancer-predisposing syndrome [RCV001011341]|not provided [RCV000808897] | Chr16:2046367 [GRCh38] Chr16:2096368 [GRCh37] Chr16:16p13.3 |
pathogenic|likely pathogenic |
NM_002528.7(NTHL1):c.395G>C (p.Ser132Thr) | single nucleotide variant | not provided [RCV000805617] | Chr16:2044760 [GRCh38] Chr16:2094761 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.685+5G>C | single nucleotide variant | not provided [RCV000822105] | Chr16:2043562 [GRCh38] Chr16:2093563 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.604G>T (p.Glu202Ter) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003458215]|Hereditary cancer-predisposing syndrome [RCV002363103]|not provided [RCV000811739] | Chr16:2043648 [GRCh38] Chr16:2093649 [GRCh37] Chr16:16p13.3 |
pathogenic|likely pathogenic |
NM_002528.7(NTHL1):c.334G>A (p.Asp112Asn) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002257986]|not provided [RCV000820392] | Chr16:2046148 [GRCh38] Chr16:2096149 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.193A>G (p.Ser65Gly) | single nucleotide variant | not provided [RCV000820414] | Chr16:2046289 [GRCh38] Chr16:2096290 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.344C>T (p.Ala115Val) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV004569605]|Hereditary cancer-predisposing syndrome [RCV002345803]|not provided [RCV000804052] | Chr16:2046138 [GRCh38] Chr16:2096139 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.152G>A (p.Arg51Gln) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001013093]|not provided [RCV000805683] | Chr16:2046330 [GRCh38] Chr16:2096331 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.457G>T (p.Val153Leu) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003467412]|Hereditary cancer-predisposing syndrome [RCV002336636]|not provided [RCV000805696] | Chr16:2044698 [GRCh38] Chr16:2094699 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.768C>T (p.Ala256=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002416185]|not provided [RCV000938028] | Chr16:2040156 [GRCh38] Chr16:2090157 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.446G>A (p.Arg149Gln) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003461109]|Hereditary cancer-predisposing syndrome [RCV002256512]|not provided [RCV000799034] | Chr16:2044709 [GRCh38] Chr16:2094710 [GRCh37] Chr16:16p13.3 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_002528.7(NTHL1):c.823G>A (p.Val275Met) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001017881]|not provided [RCV000802310] | Chr16:2040016 [GRCh38] Chr16:2090017 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.160C>T (p.Gln54Ter) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003458217]|Hereditary cancer-predisposing syndrome [RCV004029040]|not provided [RCV000820504] | Chr16:2046322 [GRCh38] Chr16:2096323 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.47G>C (p.Gly16Ala) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002370084]|not provided [RCV000795884] | Chr16:2047777 [GRCh38] Chr16:2097778 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_002528.7(NTHL1):c.252G>C (p.Trp84Cys) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV004569680]|Hereditary cancer-predisposing syndrome [RCV002255533]|not provided [RCV000812392] | Chr16:2046230 [GRCh38] Chr16:2096231 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.488C>T (p.Thr163Met) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003467490]|Hereditary cancer-predisposing syndrome [RCV002345882]|NTHL1-related disorder [RCV004751737]|not provided [RCV000818852] | Chr16:2044667 [GRCh38] Chr16:2094668 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.81G>C (p.Glu27Asp) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002397717]|not provided [RCV000820565] | Chr16:2047743 [GRCh38] Chr16:2097744 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.115+1G>A | single nucleotide variant | Familial adenomatous polyposis 3 [RCV000989411]|Hereditary cancer-predisposing syndrome [RCV001011335]|not provided [RCV000813400] | Chr16:2047708 [GRCh38] Chr16:2097709 [GRCh37] Chr16:16p13.3 |
pathogenic|likely pathogenic |
NM_002528.7(NTHL1):c.682A>G (p.Ile228Val) | single nucleotide variant | not provided [RCV000815803] | Chr16:2043570 [GRCh38] Chr16:2093571 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.889C>G (p.Leu297Val) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002370108]|not provided [RCV000799505] | Chr16:2039950 [GRCh38] Chr16:2089951 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.68G>A (p.Gly23Glu) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003467494]|Hereditary cancer-predisposing syndrome [RCV002372336]|not provided [RCV000819939] | Chr16:2047756 [GRCh38] Chr16:2097757 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.50C>A (p.Pro17His) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002388469]|not provided [RCV000799812] | Chr16:2047774 [GRCh38] Chr16:2097775 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.421G>A (p.Gly141Ser) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV004569718]|Hereditary cancer-predisposing syndrome [RCV002332684]|not provided [RCV000816444] | Chr16:2044734 [GRCh38] Chr16:2094735 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.700G>A (p.Val234Met) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003307455]|not provided [RCV000800137] | Chr16:2040224 [GRCh38] Chr16:2090225 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.36C>T (p.Ser12=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002257995]|not provided [RCV000841459] | Chr16:2047788 [GRCh38] Chr16:2097789 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.686-7C>G | single nucleotide variant | not provided [RCV000806451] | Chr16:2040245 [GRCh38] Chr16:2090246 [GRCh37] Chr16:16p13.3 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_002528.7(NTHL1):c.766G>A (p.Ala256Thr) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002422713]|not provided [RCV000796867] | Chr16:2040158 [GRCh38] Chr16:2090159 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.525+1G>A | single nucleotide variant | not provided [RCV000813282] | Chr16:2044629 [GRCh38] Chr16:2094630 [GRCh37] Chr16:16p13.3 |
likely pathogenic |
NM_002528.7(NTHL1):c.686-9T>C | single nucleotide variant | not provided [RCV000796981] | Chr16:2040247 [GRCh38] Chr16:2090248 [GRCh37] Chr16:16p13.3 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_002528.7(NTHL1):c.446G>C (p.Arg149Pro) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV004569730]|Hereditary cancer-predisposing syndrome [RCV001022934]|not provided [RCV000817467] | Chr16:2044709 [GRCh38] Chr16:2094710 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_002528.7(NTHL1):c.350C>T (p.Pro117Leu) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003467499]|Hereditary cancer-predisposing syndrome [RCV001021037]|not provided [RCV000820715]|not specified [RCV003321751] | Chr16:2046132 [GRCh38] Chr16:2096133 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.6(NTHL1):c.8G>C (p.Ser3Thr) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002370075]|not provided [RCV000794390] | Chr16:2047840 [GRCh38] Chr16:2097841 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.14G>C (p.Ser5Thr) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002257974]|not provided [RCV000807679] | Chr16:2047810 [GRCh38] Chr16:2097811 [GRCh37] Chr16:16p13.3 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_002528.7(NTHL1):c.712G>A (p.Ala238Thr) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003461127]|Hereditary cancer-predisposing syndrome [RCV001026335]|NTHL1-related disorder [RCV003928275]|not provided [RCV000801248] | Chr16:2040212 [GRCh38] Chr16:2090213 [GRCh37] Chr16:16p13.3 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_002528.7(NTHL1):c.511G>C (p.Val171Leu) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003467518]|Hereditary cancer-predisposing syndrome [RCV002345912]|not provided [RCV000823489] | Chr16:2044644 [GRCh38] Chr16:2094645 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.350dup (p.Val119fs) | duplication | Familial adenomatous polyposis 3 [RCV003458216]|Hereditary cancer-predisposing syndrome [RCV002363139]|not provided [RCV000817862] | Chr16:2046131..2046132 [GRCh38] Chr16:2096132..2096133 [GRCh37] Chr16:16p13.3 |
pathogenic|likely pathogenic |
NM_002528.7(NTHL1):c.797T>C (p.Leu266Pro) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV004569616]|Hereditary cancer-predisposing syndrome [RCV002424866]|not provided [RCV000804692] | Chr16:2040042 [GRCh38] Chr16:2090043 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.96G>C (p.Arg32=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV004029239]|not provided [RCV000842410] | Chr16:2047728 [GRCh38] Chr16:2097729 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.-9G>A | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002397741]|not provided [RCV000823897] | Chr16:2047832 [GRCh38] Chr16:2097833 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_002528.7(NTHL1):c.763C>T (p.Arg255Cys) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV001789784]|Hereditary cancer-predisposing syndrome [RCV001026902]|not provided [RCV000814330] | Chr16:2040161 [GRCh38] Chr16:2090162 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.625G>A (p.Val209Ile) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003461289]|Hereditary cancer-predisposing syndrome [RCV002256555]|not provided [RCV000824271] | Chr16:2043627 [GRCh38] Chr16:2093628 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.703C>T (p.His235Tyr) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003467339]|Hereditary cancer-predisposing syndrome [RCV002386390]|not provided [RCV000794237] | Chr16:2040221 [GRCh38] Chr16:2090222 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.652A>G (p.Met218Val) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003467389]|Hereditary cancer-predisposing syndrome [RCV001025626]|NTHL1-related disorder [RCV003928276]|not provided [RCV000802228] | Chr16:2043600 [GRCh38] Chr16:2093601 [GRCh37] Chr16:16p13.3 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_002528.7(NTHL1):c.149C>T (p.Pro50Leu) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV001535481]|Hereditary cancer-predisposing syndrome [RCV001012937]|not provided [RCV000794648] | Chr16:2046333 [GRCh38] Chr16:2096334 [GRCh37] Chr16:16p13.3 |
uncertain significance|not provided |
NM_002528.7(NTHL1):c.769G>A (p.Ala257Thr) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV002291703]|Hereditary cancer-predisposing syndrome [RCV001026979]|NTHL1-related disorder [RCV004751726]|not provided [RCV000811178]|not specified [RCV003320216] | Chr16:2040155 [GRCh38] Chr16:2090156 [GRCh37] Chr16:16p13.3 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_002528.7(NTHL1):c.349C>T (p.Pro117Ser) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003472343]|Hereditary cancer-predisposing syndrome [RCV001021012]|NTHL1-related disorder [RCV004751707]|not provided [RCV000794718] | Chr16:2046133 [GRCh38] Chr16:2096134 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.44T>C (p.Leu15Pro) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001025785]|NTHL1-related disorder [RCV003396450]|not provided [RCV000822008] | Chr16:2047780 [GRCh38] Chr16:2097781 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.275G>A (p.Arg92His) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV004569588]|Hereditary cancer-predisposing syndrome [RCV001017892]|Lymphangiomyomatosis [RCV002501079]|NTHL1-related disorder [RCV004751716]|not provided [RCV000802521]|not specified [RCV002268292] | Chr16:2046207 [GRCh38] Chr16:2096208 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.20G>C (p.Arg7Thr) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV002478924]|Hereditary cancer-predisposing syndrome [RCV002255542]|NTHL1-related disorder [RCV003396453]|not provided [RCV000822195]|not specified [RCV003493744] | Chr16:2047804 [GRCh38] Chr16:2097805 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.431A>G (p.Gln144Arg) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003166170]|not provided [RCV000798856] | Chr16:2044724 [GRCh38] Chr16:2094725 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.354+30dup | duplication | not provided [RCV000839417]|not specified [RCV002268337] | Chr16:2046092..2046093 [GRCh38] Chr16:2096093..2096094 [GRCh37] Chr16:16p13.3 |
benign|likely benign |
NM_002528.7(NTHL1):c.604G>A (p.Glu202Lys) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003467344]|Hereditary cancer-predisposing syndrome [RCV002256505]|not provided [RCV000795061]|not specified [RCV004596347] | Chr16:2043648 [GRCh38] Chr16:2093649 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.119C>T (p.Ala40Val) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003461187]|Hereditary cancer-predisposing syndrome [RCV001011586]|not provided [RCV000809621] | Chr16:2046363 [GRCh38] Chr16:2096364 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.784C>G (p.Leu262Val) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV004570229]|Hereditary cancer-predisposing syndrome [RCV002418506]|not provided [RCV001057748] | Chr16:2040140 [GRCh38] Chr16:2090141 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.468C>T (p.Ile156=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001023276]|not provided [RCV001473380] | Chr16:2044687 [GRCh38] Chr16:2094688 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.655G>C (p.Ala219Pro) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002363093]|not provided [RCV000810584] | Chr16:2043597 [GRCh38] Chr16:2093598 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.73A>T (p.Arg25Trp) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002381801]|not provided [RCV000810751] | Chr16:2047751 [GRCh38] Chr16:2097752 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.401C>T (p.Thr134Ile) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002332599]|not provided [RCV000795750] | Chr16:2044754 [GRCh38] Chr16:2094755 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.460del (p.Asp154fs) | deletion | Familial adenomatous polyposis 3 [RCV003458211]|Hereditary cancer-predisposing syndrome [RCV002332650]|not provided [RCV000806724] | Chr16:2044695 [GRCh38] Chr16:2094696 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.105G>C (p.Glu35Asp) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003325217]|not provided [RCV000806754] | Chr16:2047719 [GRCh38] Chr16:2097720 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.748T>A (p.Ser250Thr) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001026764]|NTHL1-related disorder [RCV004751727]|not provided [RCV000812645] | Chr16:2040176 [GRCh38] Chr16:2090177 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.62C>T (p.Pro21Leu) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003362963]|not provided [RCV000808163] | Chr16:2047762 [GRCh38] Chr16:2097763 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.661G>T (p.Ala221Ser) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003467444]|Hereditary cancer-predisposing syndrome [RCV002363094]|not provided [RCV000810736] | Chr16:2043591 [GRCh38] Chr16:2093592 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.547C>T (p.Gln183Ter) | single nucleotide variant | not provided [RCV001052800] | Chr16:2043705 [GRCh38] Chr16:2093706 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_002528.6(NTHL1):c.5G>A (p.Cys2Tyr) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002352373]|not provided [RCV000803833] | Chr16:2047843 [GRCh38] Chr16:2097844 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.804C>G (p.His268Gln) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002424810]|not provided [RCV000794651] | Chr16:2040035 [GRCh38] Chr16:2090036 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.194G>A (p.Ser65Asn) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002422698]|not provided [RCV000794751] | Chr16:2046288 [GRCh38] Chr16:2096289 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.42C>G (p.Ser14Arg) | single nucleotide variant | not provided [RCV001054556] | Chr16:2047782 [GRCh38] Chr16:2097783 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.348C>T (p.Pro116=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001020990]|not provided [RCV002069008] | Chr16:2046134 [GRCh38] Chr16:2096135 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.6(NTHL1):c.1A>G (p.Met1Val) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001013979]|not provided [RCV000811579] | Chr16:2047847 [GRCh38] Chr16:2097848 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.89C>G (p.Pro30Arg) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001009990]|not provided [RCV000809382] | Chr16:2047735 [GRCh38] Chr16:2097736 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.7G>T (p.Ala3Ser) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003133619]|Hereditary cancer-predisposing syndrome [RCV001019155]|not provided [RCV000798390] | Chr16:2047817 [GRCh38] Chr16:2097818 [GRCh37] Chr16:16p13.3 |
conflicting interpretations of pathogenicity|uncertain significance |
NC_000016.9:g.(?_2089915)_(2110824_?)dup | duplication | Tuberous sclerosis 2 [RCV000821273] | Chr16:2039914..2060823 [GRCh38] Chr16:2089915..2110824 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.455C>A (p.Thr152Lys) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV002290452]|Hereditary cancer-predisposing syndrome [RCV002336641]|not provided [RCV000806725] | Chr16:2044700 [GRCh38] Chr16:2094701 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.472C>T (p.Gln158Ter) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003458214]|Hereditary cancer-predisposing syndrome [RCV001023343]|not provided [RCV000810184] | Chr16:2044683 [GRCh38] Chr16:2094684 [GRCh37] Chr16:16p13.3 |
pathogenic|likely pathogenic |
NM_002528.7(NTHL1):c.802C>T (p.His268Tyr) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002406832]|not provided [RCV000812351] | Chr16:2040037 [GRCh38] Chr16:2090038 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.392C>T (p.Ser131Phe) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002332611]|not provided [RCV000798514] | Chr16:2044763 [GRCh38] Chr16:2094764 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.731C>G (p.Thr244Ser) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV004569579]|Hereditary cancer-predisposing syndrome [RCV001026563]|not provided [RCV000801792] | Chr16:2040193 [GRCh38] Chr16:2090194 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.268A>G (p.Asn90Asp) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003467487]|Hereditary cancer-predisposing syndrome [RCV001017522]|not provided [RCV000818344] | Chr16:2046214 [GRCh38] Chr16:2096215 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.332A>G (p.Tyr111Cys) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003467387]|Hereditary cancer-predisposing syndrome [RCV002256518]|not provided [RCV000801950]|not specified [RCV003321744] | Chr16:2046150 [GRCh38] Chr16:2096151 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.807G>A (p.Glu269=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002427426]|not provided [RCV000980024] | Chr16:2040032 [GRCh38] Chr16:2090033 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.7G>A (p.Ala3Thr) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002325530]|not provided [RCV000798868]|not specified [RCV003320213] | Chr16:2047817 [GRCh38] Chr16:2097818 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.356_359dup (p.Arg121fs) | duplication | Familial adenomatous polyposis 3 [RCV003458207]|Hereditary cancer-predisposing syndrome [RCV002352342]|not provided [RCV000798872] | Chr16:2044795..2044796 [GRCh38] Chr16:2094796..2094797 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.46G>C (p.Gly16Arg) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV001294000]|Hereditary cancer-predisposing syndrome [RCV002255539]|not provided [RCV000818618] | Chr16:2047778 [GRCh38] Chr16:2097779 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.370G>T (p.Val124Leu) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001021501]|not provided [RCV000802241] | Chr16:2044785 [GRCh38] Chr16:2094786 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.439C>T (p.Arg147Trp) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV004569543]|Hereditary cancer-predisposing syndrome [RCV002259018]|not provided [RCV000796472] | Chr16:2044716 [GRCh38] Chr16:2094717 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.242C>T (p.Pro81Leu) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003467357]|Hereditary cancer-predisposing syndrome [RCV001016262]|NTHL1-related disorder [RCV003413596]|not provided [RCV000796495] | Chr16:2046240 [GRCh38] Chr16:2096241 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.354+2T>C | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003458210]|not provided [RCV000805618] | Chr16:2046126 [GRCh38] Chr16:2096127 [GRCh37] Chr16:16p13.3 |
likely pathogenic |
NM_002528.7(NTHL1):c.731C>T (p.Thr244Ile) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003467510]|Hereditary cancer-predisposing syndrome [RCV002390698]|not provided [RCV000822251] | Chr16:2040193 [GRCh38] Chr16:2090194 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.696G>A (p.Thr232=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002372619]|not provided [RCV000939744] | Chr16:2040228 [GRCh38] Chr16:2090229 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.589C>G (p.Pro197Ala) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV004569687]|Hereditary cancer-predisposing syndrome [RCV003353048]|not provided [RCV000813038] | Chr16:2043663 [GRCh38] Chr16:2093664 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.102A>T (p.Arg34Ser) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV004569591]|Hereditary cancer-predisposing syndrome [RCV001010673]|not provided [RCV000802631] | Chr16:2047722 [GRCh38] Chr16:2097723 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.85G>A (p.Gly29Arg) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV004569771]|Hereditary cancer-predisposing syndrome [RCV002256547]|NTHL1-related disorder [RCV004751746]|not provided [RCV000822332]|not specified [RCV001816908] | Chr16:2047739 [GRCh38] Chr16:2097740 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.150G>A (p.Pro50=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002256626]|not provided [RCV000939120] | Chr16:2046332 [GRCh38] Chr16:2096333 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.103G>C (p.Glu35Gln) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003461171]|Hereditary cancer-predisposing syndrome [RCV001010720]|not provided [RCV000807595] | Chr16:2047721 [GRCh38] Chr16:2097722 [GRCh37] Chr16:16p13.3 |
conflicting interpretations of pathogenicity|uncertain significance |
NC_000016.9:g.(?_2089915)_(2138621_?)dup | duplication | Tuberous sclerosis 2 [RCV000795442] | Chr16:2039914..2088620 [GRCh38] Chr16:2089915..2138621 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.611T>G (p.Val204Gly) | single nucleotide variant | not provided [RCV000802829] | Chr16:2043641 [GRCh38] Chr16:2093642 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.37C>T (p.Arg13Trp) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003467393]|Hereditary cancer-predisposing syndrome [RCV001024999]|NTHL1-related disorder [RCV003947990]|not provided [RCV000802855] | Chr16:2047787 [GRCh38] Chr16:2097788 [GRCh37] Chr16:16p13.3 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_002528.7(NTHL1):c.423C>T (p.Gly141=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001022546]|not provided [RCV000939974] | Chr16:2044732 [GRCh38] Chr16:2094733 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.499C>G (p.Leu167Val) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003461175]|not provided [RCV000807961] | Chr16:2044656 [GRCh38] Chr16:2094657 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.440G>A (p.Arg147Gln) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV004569530]|Hereditary cancer-predisposing syndrome [RCV002334474]|not provided [RCV000794553] | Chr16:2044715 [GRCh38] Chr16:2094716 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.91C>T (p.Leu31Phe) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV004569715]|Hereditary cancer-predisposing syndrome [RCV002257982]|not provided [RCV000815980] | Chr16:2047733 [GRCh38] Chr16:2097734 [GRCh37] Chr16:16p13.3 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_002528.7(NTHL1):c.434G>T (p.Arg145Leu) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002336689]|not provided [RCV000816025] | Chr16:2044721 [GRCh38] Chr16:2094722 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.32G>A (p.Arg11Gln) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003467330]|Hereditary cancer-predisposing syndrome [RCV001024430]|not provided [RCV000792050] | Chr16:2047792 [GRCh38] Chr16:2097793 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.259C>T (p.Gln87Ter) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003362964]|not provided [RCV000808595] | Chr16:2046223 [GRCh38] Chr16:2096224 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.269A>T (p.Asn90Ile) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002440752]|not provided [RCV000811253] | Chr16:2046213 [GRCh38] Chr16:2096214 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.126A>T (p.Lys42Asn) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002388499]|not provided [RCV000803402] | Chr16:2046356 [GRCh38] Chr16:2096357 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.443C>T (p.Ala148Val) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003467360]|Hereditary cancer-predisposing syndrome [RCV002334490]|NTHL1-related disorder [RCV003411752]|not provided [RCV000796990]|not specified [RCV003321737] | Chr16:2044712 [GRCh38] Chr16:2094713 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.151C>T (p.Arg51Trp) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003467468]|Hereditary cancer-predisposing syndrome [RCV001013001]|NTHL1-related disorder [RCV004751728]|not provided [RCV000813521] | Chr16:2046331 [GRCh38] Chr16:2096332 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.901G>A (p.Ala301Thr) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002442653]|not provided [RCV000800193] | Chr16:2039938 [GRCh38] Chr16:2089939 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.747G>C (p.Lys249Asn) | single nucleotide variant | not provided [RCV000800260] | Chr16:2040177 [GRCh38] Chr16:2090178 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.246_247delinsAT (p.Asp83Tyr) | indel | Hereditary cancer-predisposing syndrome [RCV002424861]|not provided [RCV000803580] | Chr16:2046235..2046236 [GRCh38] Chr16:2096236..2096237 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.235T>G (p.Trp79Gly) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV004028727]|not provided [RCV000811448] | Chr16:2046247 [GRCh38] Chr16:2096248 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.58G>A (p.Gly20Arg) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001027384]|not provided [RCV000809021] | Chr16:2047766 [GRCh38] Chr16:2097767 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_002528.7(NTHL1):c.416C>T (p.Thr139Met) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003467431]|Hereditary cancer-predisposing syndrome [RCV001022441]|not provided [RCV000809098] | Chr16:2044739 [GRCh38] Chr16:2094740 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.556G>A (p.Ala186Thr) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV004771486]|Hereditary cancer-predisposing syndrome [RCV002352311]|not provided [RCV000792690] | Chr16:2043696 [GRCh38] Chr16:2093697 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_002528.7(NTHL1):c.831C>T (p.Phe277=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002442772]|not provided [RCV000827272] | Chr16:2040008 [GRCh38] Chr16:2090009 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.29C>G (p.Thr10Ser) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003467472]|Hereditary cancer-predisposing syndrome [RCV001024035]|not provided [RCV000814011]|not specified [RCV004596353] | Chr16:2047795 [GRCh38] Chr16:2097796 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_002528.7(NTHL1):c.353A>T (p.Lys118Met) | single nucleotide variant | not provided [RCV000797657] | Chr16:2046129 [GRCh38] Chr16:2096130 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.139G>A (p.Val47Met) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002255529]|NTHL1-related disorder [RCV003947993]|not provided [RCV000804043] | Chr16:2046343 [GRCh38] Chr16:2096344 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.31C>T (p.Arg11Trp) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV002478928]|Hereditary cancer-predisposing syndrome [RCV001024310]|not provided [RCV000823099] | Chr16:2047793 [GRCh38] Chr16:2097794 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.476C>T (p.Thr159Ile) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003467516]|Hereditary cancer-predisposing syndrome [RCV002336719]|not provided [RCV000823124] | Chr16:2044679 [GRCh38] Chr16:2094680 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.792-3C>T | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001027234]|NTHL1-related disorder [RCV003958053]|not provided [RCV000896292]|not specified [RCV002479026] | Chr16:2040050 [GRCh38] Chr16:2090051 [GRCh37] Chr16:16p13.3 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_002528.7(NTHL1):c.743C>G (p.Thr248Ser) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002397568]|not provided [RCV000792812] | Chr16:2040181 [GRCh38] Chr16:2090182 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.358C>G (p.Arg120Gly) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003153859]|Hereditary cancer-predisposing syndrome [RCV001021245]|not provided [RCV000817334] | Chr16:2044797 [GRCh38] Chr16:2094798 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.491T>C (p.Leu164Pro) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003461125]|Hereditary cancer-predisposing syndrome [RCV002336604]|not provided [RCV000800987] | Chr16:2044664 [GRCh38] Chr16:2094665 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.391_392del (p.Ser131fs) | microsatellite | Familial adenomatous polyposis 3 [RCV003458218]|Hereditary cancer-predisposing syndrome [RCV002332722]|not provided [RCV000823544] | Chr16:2044763..2044764 [GRCh38] Chr16:2094764..2094765 [GRCh37] Chr16:16p13.3 |
pathogenic|likely pathogenic |
NM_002528.7(NTHL1):c.583G>A (p.Asp195Asn) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV004569699]|Hereditary cancer-predisposing syndrome [RCV001024871]|not provided [RCV000814427] | Chr16:2043669 [GRCh38] Chr16:2093670 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.577G>A (p.Gly193Ser) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003153862]|Hereditary cancer-predisposing syndrome [RCV001024816]|not provided [RCV000817579]|not specified [RCV002268310] | Chr16:2043675 [GRCh38] Chr16:2093676 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.346C>A (p.Pro116Thr) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001020940]|not provided [RCV000804461] | Chr16:2046136 [GRCh38] Chr16:2096137 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_002528.7(NTHL1):c.686-99G>A | single nucleotide variant | not provided [RCV000839475] | Chr16:2040337 [GRCh38] Chr16:2090338 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.792-3C>A | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002422705]|not provided [RCV000795639] | Chr16:2040050 [GRCh38] Chr16:2090051 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.877C>G (p.Leu293Val) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003461223]|Hereditary cancer-predisposing syndrome [RCV001018659]|not provided [RCV000814532] | Chr16:2039962 [GRCh38] Chr16:2089963 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_002528.7(NTHL1):c.-8A>T | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002258118]|not provided [RCV001060151] | Chr16:2047831 [GRCh38] Chr16:2097832 [GRCh37] Chr16:16p13.3 |
uncertain significance |
GRCh37/hg19 16p13.3(chr16:2070917-2592737)x3 | copy number gain | not provided [RCV000845878] | Chr16:2070917..2592737 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.677C>T (p.Ser226Leu) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003467778]|Hereditary cancer-predisposing syndrome [RCV002258111]|not provided [RCV001055126] | Chr16:2043575 [GRCh38] Chr16:2093576 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.232G>C (p.Val78Leu) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003307879]|not provided [RCV001056028] | Chr16:2046250 [GRCh38] Chr16:2096251 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.15C>A (p.Ser5Arg) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001021615]|not provided [RCV001044455] | Chr16:2047809 [GRCh38] Chr16:2097810 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.390C>G (p.Leu130=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001021951]|not provided [RCV001416922] | Chr16:2044765 [GRCh38] Chr16:2094766 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.350C>A (p.Pro117Gln) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV004570255]|Hereditary cancer-predisposing syndrome [RCV002348448]|not provided [RCV001062099] | Chr16:2046132 [GRCh38] Chr16:2096133 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.10:g.(?_1523498)_(2064447_?)del | deletion | Tuberous sclerosis 2 [RCV001032344] | Chr16:1573499..2114448 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.555C>T (p.Ser185=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001024538]|not provided [RCV000936266] | Chr16:2043697 [GRCh38] Chr16:2093698 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.483T>C (p.Asp161=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002336959]|not provided [RCV000937354] | Chr16:2044672 [GRCh38] Chr16:2094673 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.26T>C (p.Leu9Pro) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001023546]|not provided [RCV001766854] | Chr16:2047798 [GRCh38] Chr16:2097799 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.15C>G (p.Ser5Arg) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002374926]|not provided [RCV001055224] | Chr16:2047809 [GRCh38] Chr16:2097810 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.815G>C (p.Gly272Ala) | single nucleotide variant | not provided [RCV001056622] | Chr16:2040024 [GRCh38] Chr16:2090025 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.445dup (p.Arg149fs) | duplication | Hereditary cancer-predisposing syndrome [RCV001022918]|not provided [RCV003718309] | Chr16:2044709..2044710 [GRCh38] Chr16:2094710..2094711 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.357A>C (p.Val119=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001021225]|not provided [RCV001463588] | Chr16:2044798 [GRCh38] Chr16:2094799 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.358C>A (p.Arg120Ser) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001021244]|not provided [RCV003679028] | Chr16:2044797 [GRCh38] Chr16:2094798 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.493G>A (p.Gly165Ser) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV004570629]|Hereditary cancer-predisposing syndrome [RCV003365289]|not provided [RCV001246186] | Chr16:2044662 [GRCh38] Chr16:2094663 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.761C>T (p.Thr254Ile) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003469341]|Hereditary cancer-predisposing syndrome [RCV004649488]|not provided [RCV001208207] | Chr16:2040163 [GRCh38] Chr16:2090164 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.-11A>G | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002393468]|not provided [RCV001208529] | Chr16:2047834 [GRCh38] Chr16:2097835 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_002528.7(NTHL1):c.17C>A (p.Ala6Glu) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV004033896]|not provided [RCV001213594] | Chr16:2047807 [GRCh38] Chr16:2097808 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.94C>G (p.Arg32Gly) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002339660]|not provided [RCV001238757] | Chr16:2047730 [GRCh38] Chr16:2097731 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.686-3C>T | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002365947]|not provided [RCV001210584] | Chr16:2040241 [GRCh38] Chr16:2090242 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.374T>C (p.Leu125Pro) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV004649513]|not provided [RCV001222754] | Chr16:2044781 [GRCh38] Chr16:2094782 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.685+5G>A | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002366010]|not provided [RCV001224203] | Chr16:2043562 [GRCh38] Chr16:2093563 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.440G>C (p.Arg147Pro) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002327528]|not provided [RCV001222990] | Chr16:2044715 [GRCh38] Chr16:2094716 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.487_505delinsC (p.Thr163_Tyr169delinsHis) | indel | Hereditary cancer-predisposing syndrome [RCV002339672]|not provided [RCV001242759] | Chr16:2044650..2044668 [GRCh38] Chr16:2094651..2094669 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.254A>T (p.Gln85Leu) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003353232]|not provided [RCV001231831] | Chr16:2046228 [GRCh38] Chr16:2096229 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.74G>T (p.Arg25Met) | single nucleotide variant | not provided [RCV001224653] | Chr16:2047750 [GRCh38] Chr16:2097751 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.869A>G (p.His290Arg) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002375199]|not provided [RCV001220479] | Chr16:2039970 [GRCh38] Chr16:2089971 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.670A>C (p.Thr224Pro) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002366058]|NTHL1-related disorder [RCV004731108]|not provided [RCV001240161] | Chr16:2043582 [GRCh38] Chr16:2093583 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.387G>A (p.Met129Ile) | single nucleotide variant | not provided [RCV001227181] | Chr16:2044768 [GRCh38] Chr16:2094769 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.449G>T (p.Gly150Val) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002339571]|not provided [RCV001218094] | Chr16:2044706 [GRCh38] Chr16:2094707 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.1A>G (p.Met1Val) | single nucleotide variant | not provided [RCV001227472] | Chr16:2047823 [GRCh38] Chr16:2097824 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.2T>C (p.Met1Thr) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002436967]|not provided [RCV001245877] | Chr16:2047822 [GRCh38] Chr16:2097823 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.224A>C (p.Lys75Thr) | single nucleotide variant | not provided [RCV001218461] | Chr16:2046258 [GRCh38] Chr16:2096259 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.287A>G (p.Asn96Ser) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003294055]|not provided [RCV001218531] | Chr16:2046195 [GRCh38] Chr16:2096196 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_002528.7(NTHL1):c.237G>C (p.Trp79Cys) | single nucleotide variant | not provided [RCV001219220] | Chr16:2046245 [GRCh38] Chr16:2096246 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.713C>T (p.Ala238Val) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003462745]|Hereditary cancer-predisposing syndrome [RCV002379826]|not provided [RCV001219222] | Chr16:2040211 [GRCh38] Chr16:2090212 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.182A>G (p.Glu61Gly) | single nucleotide variant | not provided [RCV001247492] | Chr16:2046300 [GRCh38] Chr16:2096301 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.296A>C (p.Asp99Ala) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002322061]|not provided [RCV001219533] | Chr16:2046186 [GRCh38] Chr16:2096187 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.434G>A (p.Arg145Gln) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001022746]|not provided [RCV001065539] | Chr16:2044721 [GRCh38] Chr16:2094722 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.673G>A (p.Val225Met) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003230278]|Hereditary cancer-predisposing syndrome [RCV002374956]|not provided [RCV001061913] | Chr16:2043579 [GRCh38] Chr16:2093580 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.342T>G (p.Ser114Arg) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002348700]|not provided [RCV001212455] | Chr16:2046140 [GRCh38] Chr16:2096141 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_002528.7(NTHL1):c.629G>C (p.Gly210Ala) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002365904]|not provided [RCV001201912] | Chr16:2043623 [GRCh38] Chr16:2093624 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.82C>A (p.Pro28Thr) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003162124]|not provided [RCV003104727] | Chr16:2047742 [GRCh38] Chr16:2097743 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.9:g.(?_2089925)_(2115656_?)del | deletion | Tuberous sclerosis 2 [RCV003105246] | Chr16:2089925..2115656 [GRCh37] Chr16:16p13.3 |
pathogenic |
NC_000016.9:g.(?_2093558)_(2130388_?)del | deletion | Tuberous sclerosis 2 [RCV003105247] | Chr16:2093558..2130388 [GRCh37] Chr16:16p13.3 |
pathogenic |
NC_000016.9:g.(?_2089925)_(2094811_?)dup | duplication | not provided [RCV003107710] | Chr16:2089925..2094811 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.9:g.(?_2093854)_(2096278_?)del | deletion | not provided [RCV003107711] | Chr16:2093854..2096278 [GRCh37] Chr16:16p13.3 |
likely pathogenic |
NM_002528.7(NTHL1):c.42_43del (p.Leu15fs) | deletion | Hereditary cancer-predisposing syndrome [RCV003293266] | Chr16:2047781..2047782 [GRCh38] Chr16:2097782..2097783 [GRCh37] Chr16:16p13.3 |
likely pathogenic |
NM_002528.7(NTHL1):c.355-277G>A | single nucleotide variant | not provided [RCV001589327] | Chr16:2045077 [GRCh38] Chr16:2095078 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.*6G>T | single nucleotide variant | not provided [RCV001587108] | Chr16:2039918 [GRCh38] Chr16:2089919 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.115+4G>A | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002388611]|not provided [RCV001584661] | Chr16:2047705 [GRCh38] Chr16:2097706 [GRCh37] Chr16:16p13.3 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_002528.7(NTHL1):c.234C>G (p.Val78=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV004030007]|not provided [RCV000978047] | Chr16:2046248 [GRCh38] Chr16:2096249 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.174G>A (p.Val58=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001013966]|not provided [RCV000940324]|not specified [RCV003321768] | Chr16:2046308 [GRCh38] Chr16:2096309 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.684T>C (p.Ile228=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV004030082]|not provided [RCV000983606] | Chr16:2043568 [GRCh38] Chr16:2093569 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.456G>T (p.Thr152=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002336975]|not provided [RCV000940961] | Chr16:2044699 [GRCh38] Chr16:2094700 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.120G>A (p.Ala40=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002390942]|not provided [RCV000930550]|not specified [RCV002268358] | Chr16:2046362 [GRCh38] Chr16:2096363 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.534G>A (p.Val178=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002346138]|not provided [RCV000941139] | Chr16:2043718 [GRCh38] Chr16:2093719 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.699T>C (p.His233=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001026189]|not provided [RCV000938267] | Chr16:2040225 [GRCh38] Chr16:2090226 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.615G>A (p.Ala205=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002363413]|not provided [RCV000936526] | Chr16:2043637 [GRCh38] Chr16:2093638 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.189G>A (p.Ser63=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002258066]|not provided [RCV000941315] | Chr16:2046293 [GRCh38] Chr16:2096294 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.222C>G (p.Leu74=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001015456]|not provided [RCV000936674]|not specified [RCV003151224] | Chr16:2046260 [GRCh38] Chr16:2096261 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.113C>T (p.Ala38Val) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001011260]|not provided [RCV000961022]|not specified [RCV002268378] | Chr16:2047711 [GRCh38] Chr16:2097712 [GRCh37] Chr16:16p13.3 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_002528.7(NTHL1):c.355-4G>C | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003307712]|not provided [RCV000932691] | Chr16:2044804 [GRCh38] Chr16:2094805 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_002528.7(NTHL1):c.804C>T (p.His268=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002427348]|not provided [RCV000938932] | Chr16:2040035 [GRCh38] Chr16:2090036 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.264G>A (p.Leu88=) | single nucleotide variant | not provided [RCV000975783] | Chr16:2046218 [GRCh38] Chr16:2096219 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.771C>T (p.Ala257=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002416207]|not provided [RCV000941424] | Chr16:2040153 [GRCh38] Chr16:2090154 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.74G>A (p.Arg25Lys) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001019876]|NTHL1-related disorder [RCV003955796]|not provided [RCV000879706]|not specified [RCV003321759] | Chr16:2047750 [GRCh38] Chr16:2097751 [GRCh37] Chr16:16p13.3 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_002528.7(NTHL1):c.355-4G>A | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV004029653]|not provided [RCV000937256] | Chr16:2044804 [GRCh38] Chr16:2094805 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.66G>A (p.Arg22=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001018852]|not provided [RCV000981227] | Chr16:2047758 [GRCh38] Chr16:2097759 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.743C>T (p.Thr248Ile) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001026705]|not provided [RCV000937365] | Chr16:2040181 [GRCh38] Chr16:2090182 [GRCh37] Chr16:16p13.3 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_002528.7(NTHL1):c.273C>T (p.Ile91=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001017757]|not provided [RCV000938455]|not specified [RCV003321766] | Chr16:2046209 [GRCh38] Chr16:2096210 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.264G>T (p.Leu88=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002255582]|not provided [RCV000932912] | Chr16:2046218 [GRCh38] Chr16:2096219 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.111A>G (p.Ala37=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002382151]|not provided [RCV000940366] | Chr16:2047713 [GRCh38] Chr16:2097714 [GRCh37] Chr16:16p13.3 |
likely benign|conflicting interpretations of pathogenicity |
NM_002528.7(NTHL1):c.686-4G>A | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002363368]|not provided [RCV000916805] | Chr16:2040242 [GRCh38] Chr16:2090243 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_002528.7(NTHL1):c.66G>T (p.Arg22=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002372688]|not provided [RCV000978921] | Chr16:2047758 [GRCh38] Chr16:2097759 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.93C>T (p.Leu31=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002336972]|not provided [RCV000940621] | Chr16:2047731 [GRCh38] Chr16:2097732 [GRCh37] Chr16:16p13.3 |
likely benign |
NC_000016.9:g.(?_624055)_(2148005_?)del | deletion | Tuberous sclerosis 2 [RCV001033183] | Chr16:624055..2148005 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.665G>A (p.Trp222Ter) | single nucleotide variant | not provided [RCV001219000] | Chr16:2043587 [GRCh38] Chr16:2093588 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.354+5G>A | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003469363]|not provided [RCV001214455] | Chr16:2046123 [GRCh38] Chr16:2096124 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.389T>C (p.Leu130Pro) | single nucleotide variant | not provided [RCV001203538] | Chr16:2044766 [GRCh38] Chr16:2094767 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.80delinsGG (p.Glu27fs) | indel | Familial adenomatous polyposis 3 [RCV003458312]|Hereditary cancer-predisposing syndrome [RCV004636743] | Chr16:2047744 [GRCh38] Chr16:2097745 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.58G>C (p.Gly20Arg) | single nucleotide variant | not provided [RCV001203610] | Chr16:2047766 [GRCh38] Chr16:2097767 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.791+6A>G | single nucleotide variant | not provided [RCV001227143] | Chr16:2040127 [GRCh38] Chr16:2090128 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.508C>T (p.Pro170Ser) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002348707]|not provided [RCV001213444] | Chr16:2044647 [GRCh38] Chr16:2094648 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.52G>A (p.Gly18Arg) | single nucleotide variant | not provided [RCV001239786] | Chr16:2047772 [GRCh38] Chr16:2097773 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.178T>C (p.Tyr60His) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002418667]|not provided [RCV001202509] | Chr16:2046304 [GRCh38] Chr16:2096305 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.170G>T (p.Arg57Leu) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003469267]|Hereditary cancer-predisposing syndrome [RCV002418558]|not provided [RCV001071040] | Chr16:2046312 [GRCh38] Chr16:2096313 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_002528.7(NTHL1):c.504C>G (p.Ile168Met) | single nucleotide variant | not provided [RCV001245393] | Chr16:2044651 [GRCh38] Chr16:2094652 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.192C>G (p.Asp64Glu) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003365288]|not provided [RCV001245412] | Chr16:2046290 [GRCh38] Chr16:2096291 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.115+6G>C | single nucleotide variant | not provided [RCV001216923] | Chr16:2047703 [GRCh38] Chr16:2097704 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.181G>C (p.Glu61Gln) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV004570542]|Hereditary cancer-predisposing syndrome [RCV002418773]|not provided [RCV001223824] | Chr16:2046301 [GRCh38] Chr16:2096302 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.326A>G (p.His109Arg) | single nucleotide variant | not provided [RCV001054645] | Chr16:2046156 [GRCh38] Chr16:2096157 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.755A>C (p.Glu252Ala) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002411865]|not provided [RCV001234259] | Chr16:2040169 [GRCh38] Chr16:2090170 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.10:g.(?_2039924)_(2060823_?)dup | duplication | not provided [RCV001031073] | Chr16:2089925..2110824 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.538T>C (p.Tyr180His) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV004034768]|not provided [RCV001243945] | Chr16:2043714 [GRCh38] Chr16:2093715 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.887C>T (p.Ala296Val) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003469466]|Hereditary cancer-predisposing syndrome [RCV002375292]|not provided [RCV001243959] | Chr16:2039952 [GRCh38] Chr16:2089953 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.14G>A (p.Ser5Asn) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002365712]|not provided [RCV001056296] | Chr16:2047810 [GRCh38] Chr16:2097811 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.725G>C (p.Arg242Thr) | single nucleotide variant | not provided [RCV001224848] | Chr16:2040199 [GRCh38] Chr16:2090200 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.622G>A (p.Gly208Ser) | single nucleotide variant | not provided [RCV001221197] | Chr16:2043630 [GRCh38] Chr16:2093631 [GRCh37] Chr16:16p13.3 |
uncertain significance |
GRCh37/hg19 16p13.3(chr16:2092335-2112105) | copy number loss | Polycystic kidney disease, adult type [RCV001030059] | Chr16:2092335..2112105 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.526-8T>A | single nucleotide variant | not provided [RCV001217987] | Chr16:2043734 [GRCh38] Chr16:2093735 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.123G>T (p.Arg41Ser) | single nucleotide variant | not provided [RCV001218029] | Chr16:2046359 [GRCh38] Chr16:2096360 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.131A>G (p.His44Arg) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002402677]|not provided [RCV001221499] | Chr16:2046351 [GRCh38] Chr16:2096352 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.417G>A (p.Thr139=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002332913]|not provided [RCV000935580] | Chr16:2044738 [GRCh38] Chr16:2094739 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.115+10C>A | single nucleotide variant | NTHL1-related disorder [RCV003913166]|not provided [RCV000935619]|not specified [RCV002268363] | Chr16:2047699 [GRCh38] Chr16:2097700 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.900C>T (p.Ala300=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002256614]|not provided [RCV000935663] | Chr16:2039939 [GRCh38] Chr16:2089940 [GRCh37] Chr16:16p13.3 |
benign|likely benign |
NM_002528.7(NTHL1):c.562C>T (p.Leu188=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002354801]|not provided [RCV000935637] | Chr16:2043690 [GRCh38] Chr16:2093691 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.189G>C (p.Ser63=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002427330]|not provided [RCV000935934] | Chr16:2046293 [GRCh38] Chr16:2096294 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.18G>T (p.Ala6=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002332915]|not provided [RCV000935953] | Chr16:2047806 [GRCh38] Chr16:2097807 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.513C>T (p.Val171=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002346119]|not provided [RCV000934933] | Chr16:2044642 [GRCh38] Chr16:2094643 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.408C>T (p.Asp136=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001022304]|NTHL1-related disorder [RCV003903114]|not provided [RCV000935431] | Chr16:2044747 [GRCh38] Chr16:2094748 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.711C>T (p.Ile237=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002256611]|not provided [RCV000935242] | Chr16:2040213 [GRCh38] Chr16:2090214 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.843C>A (p.Thr281=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001018170]|not provided [RCV000935285]|not specified [RCV002479081] | Chr16:2039996 [GRCh38] Chr16:2089997 [GRCh37] Chr16:16p13.3 |
benign|likely benign |
NM_002528.7(NTHL1):c.791+10T>G | single nucleotide variant | NTHL1-related disorder [RCV003970595]|not provided [RCV000935577]|not specified [RCV002268362] | Chr16:2040123 [GRCh38] Chr16:2090124 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.116-10C>G | single nucleotide variant | Familial adenomatous polyposis 3 [RCV001000828]|NTHL1-related disorder [RCV003970785]|not provided [RCV000957359]|not specified [RCV002268377] | Chr16:2046376 [GRCh38] Chr16:2096377 [GRCh37] Chr16:16p13.3 |
benign|likely benign |
NM_002528.7(NTHL1):c.888C>A (p.Ala296=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002372609]|not provided [RCV000935434] | Chr16:2039951 [GRCh38] Chr16:2089952 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.607C>T (p.Leu203=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001025134]|not provided [RCV000935464]|not specified [RCV003493759] | Chr16:2043645 [GRCh38] Chr16:2093646 [GRCh37] Chr16:16p13.3 |
likely benign|conflicting interpretations of pathogenicity |
NM_002528.7(NTHL1):c.582G>A (p.Gly194=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001024859]|not provided [RCV000936022] | Chr16:2043670 [GRCh38] Chr16:2093671 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.510C>T (p.Pro170=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002346111]|not provided [RCV000934262] | Chr16:2044645 [GRCh38] Chr16:2094646 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.17C>T (p.Ala6Val) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001022036]|not provided [RCV001207339] | Chr16:2047807 [GRCh38] Chr16:2097808 [GRCh37] Chr16:16p13.3 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_002528.7(NTHL1):c.80A>G (p.Glu27Gly) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003467774]|Hereditary cancer-predisposing syndrome [RCV003160427]|not provided [RCV001054038] | Chr16:2047744 [GRCh38] Chr16:2097745 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.428T>C (p.Met143Thr) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001022648]|not provided [RCV001068969] | Chr16:2044727 [GRCh38] Chr16:2094728 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.88C>T (p.Pro30Ser) | single nucleotide variant | not provided [RCV001056021] | Chr16:2047736 [GRCh38] Chr16:2097737 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.313C>T (p.Leu105=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001020142]|not provided [RCV002068989] | Chr16:2046169 [GRCh38] Chr16:2096170 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.502A>G (p.Ile168Val) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001023825]|not provided [RCV003565447] | Chr16:2044653 [GRCh38] Chr16:2094654 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.322G>A (p.Glu108Lys) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003461385]|Hereditary cancer-predisposing syndrome [RCV001020379]|not provided [RCV001037264] | Chr16:2046160 [GRCh38] Chr16:2096161 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.350del (p.Pro117fs) | deletion | Familial adenomatous polyposis 3 [RCV003458220]|Hereditary cancer-predisposing syndrome [RCV001021039]|not provided [RCV001382392] | Chr16:2046132 [GRCh38] Chr16:2096133 [GRCh37] Chr16:16p13.3 |
pathogenic|likely pathogenic |
NM_002528.7(NTHL1):c.685+123A>G | single nucleotide variant | not provided [RCV001581296] | Chr16:2043444 [GRCh38] Chr16:2093445 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.911T>A (p.Leu304His) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001019218]|not provided [RCV001206335] | Chr16:2039928 [GRCh38] Chr16:2089929 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.355-264A>G | single nucleotide variant | not provided [RCV001715788] | Chr16:2045064 [GRCh38] Chr16:2095065 [GRCh37] Chr16:16p13.3 |
benign |
GRCh37/hg19 16p13.3(chr16:2089477-2135939) | copy number loss | Polycystic kidney disease, adult type [RCV001030057] | Chr16:2089477..2135939 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.327C>G (p.His109Gln) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001020505] | Chr16:2046155 [GRCh38] Chr16:2096156 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.269A>G (p.Asn90Ser) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV004570280]|Hereditary cancer-predisposing syndrome [RCV002256676]|not provided [RCV001066658]|not specified [RCV002268429] | Chr16:2046213 [GRCh38] Chr16:2096214 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.116A>C (p.Glu39Ala) | single nucleotide variant | not provided [RCV001054585] | Chr16:2046366 [GRCh38] Chr16:2096367 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.-3G>C | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001015115]|not provided [RCV001066222] | Chr16:2047826 [GRCh38] Chr16:2097827 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.-3G>T | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001015117]|not provided [RCV001873260] | Chr16:2047826 [GRCh38] Chr16:2097827 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.698A>G (p.His233Arg) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002374930]|not provided [RCV001056242] | Chr16:2040226 [GRCh38] Chr16:2090227 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.39G>C (p.Arg13=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001025227]|not provided [RCV001412726] | Chr16:2047785 [GRCh38] Chr16:2097786 [GRCh37] Chr16:16p13.3 |
likely benign |
NC_000016.10:g.(?_2039914)_(2048065_?)dup | duplication | Tuberous sclerosis 2 [RCV001032335] | Chr16:2089915..2098066 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.40A>G (p.Ser14Gly) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001025341] | Chr16:2047784 [GRCh38] Chr16:2097785 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.130C>G (p.His44Asp) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001012077]|not provided [RCV001040110] | Chr16:2046352 [GRCh38] Chr16:2096353 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_002528.7(NTHL1):c.525G>A (p.Arg175=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002348470]|not provided [RCV001067945] | Chr16:2044630 [GRCh38] Chr16:2094631 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.-3G>A | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002445353]|not provided [RCV001068444] | Chr16:2047826 [GRCh38] Chr16:2097827 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.101G>A (p.Arg34Lys) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001010595] | Chr16:2047723 [GRCh38] Chr16:2097724 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.116-17C>T | single nucleotide variant | NTHL1-related disorder [RCV003921350]|not provided [RCV002077146]|not specified [RCV001700584] | Chr16:2046383 [GRCh38] Chr16:2096384 [GRCh37] Chr16:16p13.3 |
benign |
NM_002528.7(NTHL1):c.478G>A (p.Asp160Asn) | single nucleotide variant | not provided [RCV001064398] | Chr16:2044677 [GRCh38] Chr16:2094678 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.743C>A (p.Thr248Asn) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002402476]|not provided [RCV001070275] | Chr16:2040181 [GRCh38] Chr16:2090182 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.164_165del (p.Arg55fs) | microsatellite | Familial adenomatous polyposis 3 [RCV003458221]|Hereditary cancer-predisposing syndrome [RCV002411615]|not provided [RCV001070357] | Chr16:2046317..2046318 [GRCh38] Chr16:2096318..2096319 [GRCh37] Chr16:16p13.3 |
pathogenic|likely pathogenic |
NM_002528.7(NTHL1):c.382C>G (p.Leu128Val) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003467789]|Hereditary cancer-predisposing syndrome [RCV002320308]|not provided [RCV001058306] | Chr16:2044773 [GRCh38] Chr16:2094774 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.203G>A (p.Gly68Asp) | single nucleotide variant | not provided [RCV001060216] | Chr16:2046279 [GRCh38] Chr16:2096280 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.9:g.(?_624055)_(2550979_?)dup | duplication | Idiopathic generalized epilepsy [RCV001033790] | Chr16:624055..2550979 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.370G>A (p.Val124Met) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002375162]|not provided [RCV001211529] | Chr16:2044785 [GRCh38] Chr16:2094786 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.275G>C (p.Arg92Pro) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002436585]|not provided [RCV001047907] | Chr16:2046207 [GRCh38] Chr16:2096208 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NG_008412.1:g.5020A>G | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001013979] | Chr16:2047847 [GRCh38] Chr16:2097848 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.5C>T (p.Thr2Ile) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV004649423]|not provided [RCV001048330] | Chr16:2047819 [GRCh38] Chr16:2097820 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_002528.7(NTHL1):c.730A>G (p.Thr244Ala) | single nucleotide variant | NTHL1-related disorder [RCV003398947]|not provided [RCV001214526] | Chr16:2040194 [GRCh38] Chr16:2090195 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.605A>T (p.Glu202Val) | single nucleotide variant | not provided [RCV001214696] | Chr16:2043647 [GRCh38] Chr16:2093648 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.310C>T (p.His104Tyr) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002320342]|not provided [RCV001067979] | Chr16:2046172 [GRCh38] Chr16:2096173 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.533T>G (p.Val178Gly) | single nucleotide variant | not provided [RCV001040403] | Chr16:2043719 [GRCh38] Chr16:2093720 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.550A>T (p.Thr184Ser) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002348388]|not provided [RCV001048976] | Chr16:2043702 [GRCh38] Chr16:2093703 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.908G>T (p.Gly303Val) | single nucleotide variant | not provided [RCV001049092] | Chr16:2039931 [GRCh38] Chr16:2089932 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.793G>A (p.Glu265Lys) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001027252]|not provided [RCV001061092] | Chr16:2040046 [GRCh38] Chr16:2090047 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.218C>G (p.Pro73Arg) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002451605]|not provided [RCV001247107] | Chr16:2046264 [GRCh38] Chr16:2096265 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.224A>G (p.Lys75Arg) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002429632]|not provided [RCV001049202] | Chr16:2046258 [GRCh38] Chr16:2096259 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.817C>T (p.Leu273Phe) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV004031255]|not provided [RCV001041618] | Chr16:2040022 [GRCh38] Chr16:2090023 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.429G>T (p.Met143Ile) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002339256]|not provided [RCV001051180] | Chr16:2044726 [GRCh38] Chr16:2094727 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.710T>C (p.Ile237Thr) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002379511]|not provided [RCV001043244] | Chr16:2040214 [GRCh38] Chr16:2090215 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.763C>G (p.Arg255Gly) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002256663]|not provided [RCV001051543] | Chr16:2040161 [GRCh38] Chr16:2090162 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.779A>T (p.Glu260Val) | single nucleotide variant | not provided [RCV001051816] | Chr16:2040145 [GRCh38] Chr16:2090146 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.695C>T (p.Thr232Met) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002375186]|not provided [RCV001216478] | Chr16:2040229 [GRCh38] Chr16:2090230 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.791+2T>C | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003462750]|Hereditary cancer-predisposing syndrome [RCV002418757]|not provided [RCV001220484] | Chr16:2040131 [GRCh38] Chr16:2090132 [GRCh37] Chr16:16p13.3 |
pathogenic|likely pathogenic|uncertain significance |
NM_002528.7(NTHL1):c.548A>G (p.Gln183Arg) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001024455]|not provided [RCV001862289] | Chr16:2043704 [GRCh38] Chr16:2093705 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.599_600del (p.Val200fs) | microsatellite | not provided [RCV001205832] | Chr16:2043652..2043653 [GRCh38] Chr16:2093653..2093654 [GRCh37] Chr16:16p13.3 |
pathogenic|likely pathogenic |
NC_000016.10:g.(?_2039924)_(2065645_?)dup | duplication | Tuberous sclerosis 2 [RCV001345089]|not provided [RCV001031245] | Chr16:2089925..2115646 [GRCh37] Chr16:16p13.3 |
uncertain significance|no classifications from unflagged records |
NC_000016.10:g.(?_2039924)_(2040248_?)dup | duplication | not provided [RCV001031382] | Chr16:2089925..2090249 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.116-3C>T | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001011346]|not provided [RCV003769444] | Chr16:2046369 [GRCh38] Chr16:2096370 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.547C>A (p.Gln183Lys) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV004033936]|not provided [RCV001214684] | Chr16:2043705 [GRCh38] Chr16:2093706 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.541A>G (p.Ile181Val) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002348797]|not provided [RCV001236214] | Chr16:2043711 [GRCh38] Chr16:2093712 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.724A>G (p.Arg242Gly) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002391097]|not provided [RCV001036606] | Chr16:2040200 [GRCh38] Chr16:2090201 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.607C>G (p.Leu203Val) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002363594]|not provided [RCV001045286] | Chr16:2043645 [GRCh38] Chr16:2093646 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.21G>T (p.Arg7Ser) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002256698]|not provided [RCV001208008] | Chr16:2047803 [GRCh38] Chr16:2097804 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.862C>T (p.Arg288Cys) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003467824]|Hereditary cancer-predisposing syndrome [RCV002374968]|not provided [RCV001064467] | Chr16:2039977 [GRCh38] Chr16:2089978 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.10:g.(?_2039924)_(2080387_?)del | deletion | not provided [RCV001032402] | Chr16:2089925..2130388 [GRCh37] Chr16:16p13.3 |
pathogenic |
NC_000016.10:g.(?_2039924)_(2093096_?)dup | duplication | not provided [RCV001032498] | Chr16:2089925..2143097 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.10:g.(?_2043557)_(2044810_?)del | deletion | not provided [RCV001032713] | Chr16:2093558..2094811 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.104A>G (p.Glu35Gly) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002379490]|not provided [RCV001037901] | Chr16:2047720 [GRCh38] Chr16:2097721 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.358C>T (p.Arg120Cys) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003467745]|Hereditary cancer-predisposing syndrome [RCV002363597]|not provided [RCV001045946] | Chr16:2044797 [GRCh38] Chr16:2094798 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.78G>T (p.Glu26Asp) | single nucleotide variant | not provided [RCV001208148] | Chr16:2047746 [GRCh38] Chr16:2097747 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.577G>C (p.Gly193Arg) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002355021]|not provided [RCV001046791] | Chr16:2043675 [GRCh38] Chr16:2093676 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.118G>T (p.Ala40Ser) | single nucleotide variant | not provided [RCV001202275] | Chr16:2046364 [GRCh38] Chr16:2096365 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.728G>A (p.Trp243Ter) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002393598]|not provided [RCV001236415] | Chr16:2040196 [GRCh38] Chr16:2090197 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.572A>G (p.His191Arg) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002355084]|not provided [RCV001066291] | Chr16:2043680 [GRCh38] Chr16:2093681 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_002528.7(NTHL1):c.751C>G (p.Pro251Ala) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001026790] | Chr16:2040173 [GRCh38] Chr16:2090174 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.511G>A (p.Val171Ile) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003467705]|Hereditary cancer-predisposing syndrome [RCV002346244]|not provided [RCV001035640] | Chr16:2044644 [GRCh38] Chr16:2094645 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.821T>C (p.Leu274Ser) | single nucleotide variant | not provided [RCV001035837] | Chr16:2040018 [GRCh38] Chr16:2090019 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.81G>A (p.Glu27=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001009809]|not provided [RCV002068810]|not specified [RCV003493770] | Chr16:2047743 [GRCh38] Chr16:2097744 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.179A>G (p.Tyr60Cys) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001014166]|not provided [RCV001362920] | Chr16:2046303 [GRCh38] Chr16:2096304 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.354+1G>A | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003469263]|Hereditary cancer-predisposing syndrome [RCV002258127]|not provided [RCV001070359] | Chr16:2046127 [GRCh38] Chr16:2096128 [GRCh37] Chr16:16p13.3 |
likely pathogenic |
NM_002528.7(NTHL1):c.811A>T (p.Asn271Tyr) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002434438]|not provided [RCV001037612] | Chr16:2040028 [GRCh38] Chr16:2090029 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.116-1_116delinsCT | indel | not provided [RCV001037818] | Chr16:2046366..2046367 [GRCh38] Chr16:2096367..2096368 [GRCh37] Chr16:16p13.3 |
likely pathogenic |
NM_002528.7(NTHL1):c.214G>A (p.Glu72Lys) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001015375]|not provided [RCV002549417] | Chr16:2046268 [GRCh38] Chr16:2096269 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.479A>G (p.Asp160Gly) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV004034904]|not provided [RCV001247800] | Chr16:2044676 [GRCh38] Chr16:2094677 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.514G>A (p.Gly172Ser) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001024021]|not provided [RCV001063799] | Chr16:2044641 [GRCh38] Chr16:2094642 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.232del (p.Val78fs) | deletion | Familial adenomatous polyposis 3 [RCV003336244]|Hereditary cancer-predisposing syndrome [RCV001015982]|not provided [RCV002551789] | Chr16:2046250 [GRCh38] Chr16:2096251 [GRCh37] Chr16:16p13.3 |
pathogenic|likely pathogenic |
NM_002528.7(NTHL1):c.208G>T (p.Gly70Trp) | single nucleotide variant | not provided [RCV001039558] | Chr16:2046274 [GRCh38] Chr16:2096275 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.82C>T (p.Pro28Ser) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001017193]|not provided [RCV002279708] | Chr16:2047742 [GRCh38] Chr16:2097743 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_002528.7(NTHL1):c.805G>C (p.Glu269Gln) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002427498]|not provided [RCV001039953] | Chr16:2040034 [GRCh38] Chr16:2090035 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.116-9T>A | single nucleotide variant | Familial adenomatous polyposis 3 [RCV002290650]|not provided [RCV001232265] | Chr16:2046375 [GRCh38] Chr16:2096376 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.812A>G (p.Asn271Ser) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003467640]|Hereditary cancer-predisposing syndrome [RCV001017611]|not provided [RCV001067983] | Chr16:2040027 [GRCh38] Chr16:2090028 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.594C>G (p.Ala198=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001024983]|not provided [RCV001483652] | Chr16:2043658 [GRCh38] Chr16:2093659 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.37C>A (p.Arg13=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001024996] | Chr16:2047787 [GRCh38] Chr16:2097788 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.448G>A (p.Gly150Ser) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002339203]|not provided [RCV001040980] | Chr16:2044707 [GRCh38] Chr16:2094708 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.394A>G (p.Ser132Gly) | single nucleotide variant | not provided [RCV001041118] | Chr16:2044761 [GRCh38] Chr16:2094762 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.359G>T (p.Arg120Leu) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV004570476]|Hereditary cancer-predisposing syndrome [RCV002365969]|not provided [RCV001215684] | Chr16:2044796 [GRCh38] Chr16:2094797 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.-11A>T | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV001011915]|not provided [RCV001247869] | Chr16:2047834 [GRCh38] Chr16:2097835 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.152G>T (p.Arg51Leu) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002402450]|not provided [RCV001064629] | Chr16:2046330 [GRCh38] Chr16:2096331 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_002528.6(NTHL1):c.5G>T (p.Cys2Phe) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002354989]|not provided [RCV001038754] | Chr16:2047843 [GRCh38] Chr16:2097844 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.649G>A (p.Ala217Thr) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV004570053]|Hereditary cancer-predisposing syndrome [RCV001025598]|not provided [RCV001058023] | Chr16:2043603 [GRCh38] Chr16:2093604 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.871G>A (p.Ala291Thr) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV004569971]|Hereditary cancer-predisposing syndrome [RCV001018550]|NTHL1-related disorder [RCV004751856]|not provided [RCV001036786] | Chr16:2039968 [GRCh38] Chr16:2089969 [GRCh37] Chr16:16p13.3 |
uncertain significance |
GRCh37/hg19 16p13.3(chr16:84485-5251013)x3 | copy number gain | not provided [RCV001537890] | Chr16:84485..5251013 [GRCh37] Chr16:16p13.3 |
pathogenic |
GRCh37/hg19 16p13.3(chr16:2011148-2161281)x3 | copy number gain | not provided [RCV001259758] | Chr16:2011148..2161281 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.129C>G (p.Ser43Arg) | single nucleotide variant | not provided [RCV001324518] | Chr16:2046353 [GRCh38] Chr16:2096354 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.183G>C (p.Glu61Asp) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002420754]|not provided [RCV001349944] | Chr16:2046299 [GRCh38] Chr16:2096300 [GRCh37] Chr16:16p13.3 |
uncertain significance |
GRCh37/hg19 16p13.3(chr16:85880-5249457)x3 | copy number gain | not provided [RCV001259749] | Chr16:85880..5249457 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.241C>G (p.Pro81Ala) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003153980]|Hereditary cancer-predisposing syndrome [RCV002256734]|not provided [RCV001303684] | Chr16:2046241 [GRCh38] Chr16:2096242 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.908G>C (p.Gly303Ala) | single nucleotide variant | not provided [RCV001319530] | Chr16:2039931 [GRCh38] Chr16:2089932 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.259C>G (p.Gln87Glu) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002438726]|not provided [RCV001319571] | Chr16:2046223 [GRCh38] Chr16:2096224 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.530A>G (p.Lys177Arg) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003469521]|Hereditary cancer-predisposing syndrome [RCV002350534]|not provided [RCV001298503] | Chr16:2043722 [GRCh38] Chr16:2093723 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.590C>T (p.Pro197Leu) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002258195]|not provided [RCV001316470] | Chr16:2043662 [GRCh38] Chr16:2093663 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.883C>G (p.Gln295Glu) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003294270]|not provided [RCV001316231] | Chr16:2039956 [GRCh38] Chr16:2089957 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.85G>C (p.Gly29Arg) | single nucleotide variant | not provided [RCV001298665] | Chr16:2047739 [GRCh38] Chr16:2097740 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.853G>A (p.Val285Met) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003166739]|not provided [RCV001306278] | Chr16:2039986 [GRCh38] Chr16:2089987 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.454A>C (p.Thr152Pro) | single nucleotide variant | not provided [RCV001296792] | Chr16:2044701 [GRCh38] Chr16:2094702 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.773T>C (p.Leu258Pro) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002418929]|not provided [RCV001306398] | Chr16:2040151 [GRCh38] Chr16:2090152 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.693C>G (p.Asp231Glu) | single nucleotide variant | not provided [RCV001303624] | Chr16:2040231 [GRCh38] Chr16:2090232 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.-7G>T | single nucleotide variant | not provided [RCV001312820] | Chr16:2047830 [GRCh38] Chr16:2097831 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.79G>C (p.Glu27Gln) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003365303]|not provided [RCV001297281] | Chr16:2047745 [GRCh38] Chr16:2097746 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.61C>T (p.Pro21Ser) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002447327]|not provided [RCV001313344] | Chr16:2047763 [GRCh38] Chr16:2097764 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.113C>G (p.Ala38Gly) | single nucleotide variant | not provided [RCV001343324] | Chr16:2047711 [GRCh38] Chr16:2097712 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.875G>A (p.Cys292Tyr) | single nucleotide variant | not provided [RCV001302018] | Chr16:2039964 [GRCh38] Chr16:2089965 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.301C>G (p.Pro101Ala) | single nucleotide variant | not provided [RCV001306104] | Chr16:2046181 [GRCh38] Chr16:2096182 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.906G>C (p.Gln302His) | single nucleotide variant | not provided [RCV001351633] | Chr16:2039933 [GRCh38] Chr16:2089934 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.12G>C (p.Leu4Phe) | single nucleotide variant | not provided [RCV001324475] | Chr16:2047812 [GRCh38] Chr16:2097813 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.887C>A (p.Ala296Asp) | single nucleotide variant | not provided [RCV001307239] | Chr16:2039952 [GRCh38] Chr16:2089953 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.862_874del (p.Arg288fs) | deletion | not provided [RCV001341424] | Chr16:2039965..2039977 [GRCh38] Chr16:2089966..2089978 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.181G>A (p.Glu61Lys) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002418891]|not provided [RCV001297044] | Chr16:2046301 [GRCh38] Chr16:2096302 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.43C>T (p.Leu15=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002368298]|not provided [RCV001415450] | Chr16:2047781 [GRCh38] Chr16:2097782 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.285G>A (p.Arg95=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002322457]|not provided [RCV001434121] | Chr16:2046197 [GRCh38] Chr16:2096198 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.89C>T (p.Pro30Leu) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003469608]|Hereditary cancer-predisposing syndrome [RCV002456572]|not provided [RCV001368551] | Chr16:2047735 [GRCh38] Chr16:2097736 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.731C>A (p.Thr244Asn) | single nucleotide variant | not provided [RCV001297608] | Chr16:2040193 [GRCh38] Chr16:2090194 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.499C>T (p.Leu167Phe) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002341793]|not provided [RCV001368483] | Chr16:2044656 [GRCh38] Chr16:2094657 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.116-10dup | duplication | not provided [RCV001422713] | Chr16:2046375..2046376 [GRCh38] Chr16:2096376..2096377 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.812A>C (p.Asn271Thr) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002437012]|not provided [RCV001297992] | Chr16:2040027 [GRCh38] Chr16:2090028 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.377T>C (p.Leu126Pro) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV004570910]|Hereditary cancer-predisposing syndrome [RCV002357259]|not provided [RCV001370421] | Chr16:2044778 [GRCh38] Chr16:2094779 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.813T>C (p.Asn271=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002255666]|not provided [RCV001433707] | Chr16:2040026 [GRCh38] Chr16:2090027 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.265dup (p.Val89fs) | duplication | Familial adenomatous polyposis 3 [RCV003458226]|Hereditary cancer-predisposing syndrome [RCV002438888]|not provided [RCV001382571] | Chr16:2046216..2046217 [GRCh38] Chr16:2096217..2096218 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.786G>A (p.Leu262=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002420880]|not provided [RCV001396858] | Chr16:2040138 [GRCh38] Chr16:2090139 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.137C>T (p.Pro46Leu) | single nucleotide variant | not provided [RCV001355289] | Chr16:2046345 [GRCh38] Chr16:2096346 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.419C>T (p.Ala140Val) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003462871]|Hereditary cancer-predisposing syndrome [RCV002327666]|not provided [RCV001304308] | Chr16:2044736 [GRCh38] Chr16:2094737 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.94C>T (p.Arg32Trp) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV002504459]|Hereditary cancer-predisposing syndrome [RCV002341606]|not provided [RCV001304317] | Chr16:2047730 [GRCh38] Chr16:2097731 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.623G>C (p.Gly208Ala) | single nucleotide variant | not provided [RCV001371082] | Chr16:2043629 [GRCh38] Chr16:2093630 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.26T>G (p.Leu9Arg) | single nucleotide variant | not provided [RCV001360416] | Chr16:2047798 [GRCh38] Chr16:2097799 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.723G>A (p.Leu241=) | single nucleotide variant | not provided [RCV001392056] | Chr16:2040201 [GRCh38] Chr16:2090202 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.846T>C (p.Cys282=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002377584]|not provided [RCV001392058] | Chr16:2039993 [GRCh38] Chr16:2089994 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.355-3C>T | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002258224]|not provided [RCV001373105] | Chr16:2044803 [GRCh38] Chr16:2094804 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.562C>G (p.Leu188Val) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002357233]|not provided [RCV001362640] | Chr16:2043690 [GRCh38] Chr16:2093691 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.850C>T (p.Pro284Ser) | single nucleotide variant | not provided [RCV001301420] | Chr16:2039989 [GRCh38] Chr16:2089990 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.706A>G (p.Arg236Gly) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV004036909]|not provided [RCV001364258] | Chr16:2040218 [GRCh38] Chr16:2090219 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.908_909delinsAA (p.Gly303Glu) | indel | not provided [RCV001305430] | Chr16:2039930..2039931 [GRCh38] Chr16:2089931..2089932 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.437T>A (p.Leu146Gln) | single nucleotide variant | not provided [RCV001339795] | Chr16:2044718 [GRCh38] Chr16:2094719 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.509C>T (p.Pro170Leu) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002350619]|not provided [RCV001340644] | Chr16:2044646 [GRCh38] Chr16:2094647 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.275G>T (p.Arg92Leu) | single nucleotide variant | not provided [RCV001342090] | Chr16:2046207 [GRCh38] Chr16:2096208 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.500T>G (p.Leu167Arg) | single nucleotide variant | not provided [RCV001322883] | Chr16:2044655 [GRCh38] Chr16:2094656 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.525+5G>T | single nucleotide variant | not provided [RCV001326497] | Chr16:2044625 [GRCh38] Chr16:2094626 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.454A>G (p.Thr152Ala) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002256744]|not provided [RCV001338611] | Chr16:2044701 [GRCh38] Chr16:2094702 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.422G>A (p.Gly141Asp) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV004035092]|not provided [RCV001323001] | Chr16:2044733 [GRCh38] Chr16:2094734 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.32G>C (p.Arg11Pro) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002350597]|not provided [RCV001323980] | Chr16:2047792 [GRCh38] Chr16:2097793 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.884A>C (p.Gln295Pro) | single nucleotide variant | not provided [RCV001324023] | Chr16:2039955 [GRCh38] Chr16:2089956 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.412G>C (p.Val138Leu) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002327652]|not provided [RCV001301663] | Chr16:2044743 [GRCh38] Chr16:2094744 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.71G>T (p.Cys24Phe) | single nucleotide variant | not provided [RCV001346801] | Chr16:2047753 [GRCh38] Chr16:2097754 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.596C>T (p.Ser199Phe) | single nucleotide variant | not provided [RCV001365248] | Chr16:2043656 [GRCh38] Chr16:2093657 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.98G>A (p.Arg33Lys) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003469540]|Hereditary cancer-predisposing syndrome [RCV002375416]|not provided [RCV001318948] | Chr16:2047726 [GRCh38] Chr16:2097727 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.877C>T (p.Leu293Phe) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002377473]|not provided [RCV001346984] | Chr16:2039962 [GRCh38] Chr16:2089963 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.373C>A (p.Leu125Met) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002375346]|not provided [RCV001298234] | Chr16:2044782 [GRCh38] Chr16:2094783 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.10:g.(?_2039924)_(2093096_?)dup | duplication | Tuberous sclerosis 2 [RCV001318970] | Chr16:2089925..2143097 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.1A>T (p.Met1Leu) | single nucleotide variant | not provided [RCV001374070] | Chr16:2047823 [GRCh38] Chr16:2097824 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.515G>A (p.Gly172Asp) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002350578]|not provided [RCV001316869] | Chr16:2044640 [GRCh38] Chr16:2094641 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.130C>T (p.His44Tyr) | single nucleotide variant | not provided [RCV001344144] | Chr16:2046352 [GRCh38] Chr16:2096353 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.422G>C (p.Gly141Ala) | single nucleotide variant | not provided [RCV001323241] | Chr16:2044733 [GRCh38] Chr16:2094734 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.347C>T (p.Pro116Leu) | single nucleotide variant | not provided [RCV001323286] | Chr16:2046135 [GRCh38] Chr16:2096136 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.704A>G (p.His235Arg) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003169819]|not provided [RCV001363328] | Chr16:2040220 [GRCh38] Chr16:2090221 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.553A>C (p.Ser185Arg) | single nucleotide variant | not provided [RCV001338207] | Chr16:2043699 [GRCh38] Chr16:2093700 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.785T>C (p.Leu262Pro) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV004570718]|not provided [RCV001307035] | Chr16:2040139 [GRCh38] Chr16:2090140 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.403A>G (p.Lys135Glu) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002327647]|not provided [RCV001300677] | Chr16:2044752 [GRCh38] Chr16:2094753 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.761C>A (p.Thr254Asn) | single nucleotide variant | not provided [RCV001300757] | Chr16:2040163 [GRCh38] Chr16:2090164 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.32GGAGCC[3] (p.11RS[3]) | microsatellite | Hereditary cancer-predisposing syndrome [RCV002368119]|not provided [RCV001339196] | Chr16:2047780..2047781 [GRCh38] Chr16:2097781..2097782 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.883C>A (p.Gln295Lys) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002447400]|not provided [RCV001341354] | Chr16:2039956 [GRCh38] Chr16:2089957 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.592G>C (p.Ala198Pro) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003469575]|not provided [RCV001343095] | Chr16:2043660 [GRCh38] Chr16:2093661 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.720G>C (p.Arg240Ser) | single nucleotide variant | not provided [RCV001344427] | Chr16:2040204 [GRCh38] Chr16:2090205 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.329G>T (p.Cys110Phe) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002456588]|not provided [RCV001373136] | Chr16:2046153 [GRCh38] Chr16:2096154 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.7G>C (p.Ala3Pro) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002322335]|not provided [RCV001363843] | Chr16:2047817 [GRCh38] Chr16:2097818 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.632C>T (p.Pro211Leu) | single nucleotide variant | not provided [RCV001350681] | Chr16:2043620 [GRCh38] Chr16:2093621 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.143A>G (p.Lys48Arg) | single nucleotide variant | not provided [RCV001325137] | Chr16:2046339 [GRCh38] Chr16:2096340 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.20G>A (p.Arg7Lys) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002327643]|not provided [RCV001298868] | Chr16:2047804 [GRCh38] Chr16:2097805 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.308A>G (p.Asp103Gly) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003169732]|not provided [RCV001350268] | Chr16:2046174 [GRCh38] Chr16:2096175 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.526-10T>G | single nucleotide variant | not provided [RCV001421201] | Chr16:2043736 [GRCh38] Chr16:2093737 [GRCh37] Chr16:16p13.3 |
likely benign|conflicting interpretations of pathogenicity |
NM_002528.7(NTHL1):c.338C>G (p.Ser113Cys) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002456459]|not provided [RCV001326774] | Chr16:2046144 [GRCh38] Chr16:2096145 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.694A>C (p.Thr232Pro) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003169851]|not provided [RCV001366230] | Chr16:2040230 [GRCh38] Chr16:2090231 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.249C>G (p.Asp83Glu) | single nucleotide variant | not provided [RCV001314044] | Chr16:2046233 [GRCh38] Chr16:2096234 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.355-10G>A | single nucleotide variant | not provided [RCV001366468] | Chr16:2044810 [GRCh38] Chr16:2094811 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_002528.7(NTHL1):c.690G>C (p.Val230=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003355466]|not provided [RCV001421625] | Chr16:2040234 [GRCh38] Chr16:2090235 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.492G>A (p.Leu164=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002341846]|not provided [RCV001396038] | Chr16:2044663 [GRCh38] Chr16:2094664 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_002528.7(NTHL1):c.188C>G (p.Ser63Trp) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002420808]|not provided [RCV001366688] | Chr16:2046294 [GRCh38] Chr16:2096295 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.346C>T (p.Pro116Ser) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002350614]|not provided [RCV001337805] | Chr16:2046136 [GRCh38] Chr16:2096137 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.257A>C (p.Gln86Pro) | single nucleotide variant | not provided [RCV001366904] | Chr16:2046225 [GRCh38] Chr16:2096226 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.20_21delinsCA (p.Arg7Thr) | indel | Hereditary cancer-predisposing syndrome [RCV002329308]|not provided [RCV001338554] | Chr16:2047803..2047804 [GRCh38] Chr16:2097804..2097805 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.623G>T (p.Gly208Val) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003298600]|not provided [RCV001368055] | Chr16:2043629 [GRCh38] Chr16:2093630 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.760A>T (p.Thr254Ser) | single nucleotide variant | not provided [RCV001368731] | Chr16:2040164 [GRCh38] Chr16:2090165 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.491T>A (p.Leu164Gln) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV004651590]|not provided [RCV001327431] | Chr16:2044664 [GRCh38] Chr16:2094665 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.10:g.(?_2039924)_(2060823_?)dup | duplication | Tuberous sclerosis 2 [RCV001318971]|not provided [RCV001031073] | Chr16:2089925..2110824 [GRCh37] Chr16:16p13.3 |
uncertain significance|no classifications from unflagged records |
NM_002528.7(NTHL1):c.379T>A (p.Ser127Thr) | single nucleotide variant | not provided [RCV001306087] | Chr16:2044776 [GRCh38] Chr16:2094777 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.863G>C (p.Arg288Pro) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002377425]|not provided [RCV001327087]|not specified [RCV004596442] | Chr16:2039976 [GRCh38] Chr16:2089977 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.209G>A (p.Gly70Glu) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002447451]|not provided [RCV001359330] | Chr16:2046273 [GRCh38] Chr16:2096274 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.110C>T (p.Ala37Val) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002384386]|not provided [RCV001312444] | Chr16:2047714 [GRCh38] Chr16:2097715 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.201A>C (p.Lys67Asn) | single nucleotide variant | not provided [RCV001351440] | Chr16:2046281 [GRCh38] Chr16:2096282 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.218C>A (p.Pro73His) | single nucleotide variant | not provided [RCV001315180] | Chr16:2046264 [GRCh38] Chr16:2096265 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.873del (p.Cys292fs) | deletion | not provided [RCV001306215] | Chr16:2039966 [GRCh38] Chr16:2089967 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.9:g.(?_624055)_(2153916_?)dup | duplication | Epilepsy [RCV001344085]|Idiopathic generalized epilepsy [RCV001316565] | Chr16:624055..2153916 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.376C>T (p.Leu126=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002377669]|not provided [RCV001421791] | Chr16:2044779 [GRCh38] Chr16:2094780 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.355-7C>T | single nucleotide variant | not provided [RCV001502174] | Chr16:2044807 [GRCh38] Chr16:2094808 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.789T>G (p.Pro263=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003160714]|not provided [RCV001427624] | Chr16:2040135 [GRCh38] Chr16:2090136 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.348C>G (p.Pro116=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002350995]|not provided [RCV001483947] | Chr16:2046134 [GRCh38] Chr16:2096135 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.519C>T (p.Phe173=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002256814]|not provided [RCV001504313] | Chr16:2044636 [GRCh38] Chr16:2094637 [GRCh37] Chr16:16p13.3 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_002528.7(NTHL1):c.792-7C>T | single nucleotide variant | not provided [RCV001499532] | Chr16:2040054 [GRCh38] Chr16:2090055 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.510del (p.Val171fs) | deletion | Familial adenomatous polyposis 3 [RCV003458225]|Hereditary cancer-predisposing syndrome [RCV004639609]|not provided [RCV001380318] | Chr16:2044645 [GRCh38] Chr16:2094646 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.795G>A (p.Glu265=) | single nucleotide variant | not provided [RCV001475282] | Chr16:2040044 [GRCh38] Chr16:2090045 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.686-8C>T | single nucleotide variant | not provided [RCV001455262] | Chr16:2040246 [GRCh38] Chr16:2090247 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.819C>G (p.Leu273=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV004038561]|not provided [RCV001457600] | Chr16:2040020 [GRCh38] Chr16:2090021 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.789T>C (p.Pro263=) | single nucleotide variant | not provided [RCV001455351] | Chr16:2040135 [GRCh38] Chr16:2090136 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.504C>A (p.Ile168=) | single nucleotide variant | not provided [RCV001491199] | Chr16:2044651 [GRCh38] Chr16:2094652 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.363G>A (p.Arg121=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002368506]|not provided [RCV001492686] | Chr16:2044792 [GRCh38] Chr16:2094793 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.603C>G (p.Ala201=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002259134]|not provided [RCV001491520] | Chr16:2043649 [GRCh38] Chr16:2093650 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.693C>T (p.Asp231=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV004641662]|not provided [RCV001492819] | Chr16:2040231 [GRCh38] Chr16:2090232 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.105G>A (p.Glu35=) | single nucleotide variant | not provided [RCV001469446] | Chr16:2047719 [GRCh38] Chr16:2097720 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.495C>G (p.Gly165=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002334555]|not provided [RCV001504229] | Chr16:2044660 [GRCh38] Chr16:2094661 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.438G>A (p.Leu146=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002329430]|not provided [RCV001403351] | Chr16:2044717 [GRCh38] Chr16:2094718 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.177C>A (p.Ala59=) | single nucleotide variant | not provided [RCV001468248] | Chr16:2046305 [GRCh38] Chr16:2096306 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.792-9C>T | single nucleotide variant | not provided [RCV001500790] | Chr16:2040056 [GRCh38] Chr16:2090057 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.696G>C (p.Thr232=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002377849]|not provided [RCV001493157] | Chr16:2040228 [GRCh38] Chr16:2090229 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.686-2A>G | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002368218]|not provided [RCV001379596] | Chr16:2040240 [GRCh38] Chr16:2090241 [GRCh37] Chr16:16p13.3 |
likely pathogenic|uncertain significance |
NM_002528.7(NTHL1):c.27G>A (p.Leu9=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002342078]|not provided [RCV001478341] | Chr16:2047797 [GRCh38] Chr16:2097798 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.525+9T>C | single nucleotide variant | not provided [RCV001440488] | Chr16:2044621 [GRCh38] Chr16:2094622 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.762C>A (p.Thr254=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002414192]|not provided [RCV001493527] | Chr16:2040162 [GRCh38] Chr16:2090163 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.498G>A (p.Lys166=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV004038441]|not provided [RCV001445895] | Chr16:2044657 [GRCh38] Chr16:2094658 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.456G>A (p.Thr152=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002341979]|not provided [RCV001443669] | Chr16:2044699 [GRCh38] Chr16:2094700 [GRCh37] Chr16:16p13.3 |
likely benign |
NC_000016.9:g.(?_2089925)_(2114438_?)del | deletion | Tuberous sclerosis 2 [RCV001386093] | Chr16:2089925..2114438 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.186C>T (p.Gly62=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002421006]|not provided [RCV001446285] | Chr16:2046296 [GRCh38] Chr16:2096297 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.355-8A>C | single nucleotide variant | not provided [RCV001402108] | Chr16:2044808 [GRCh38] Chr16:2094809 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.791+10T>C | single nucleotide variant | NTHL1-related disorder [RCV003920955]|not provided [RCV001444010] | Chr16:2040123 [GRCh38] Chr16:2090124 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.21G>A (p.Arg7=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002341867]|not provided [RCV001403389] | Chr16:2047803 [GRCh38] Chr16:2097804 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.161dup (p.Arg55fs) | duplication | not provided [RCV001389488] | Chr16:2046320..2046321 [GRCh38] Chr16:2096321..2096322 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.573C>T (p.His191=) | single nucleotide variant | not provided [RCV001441569] | Chr16:2043679 [GRCh38] Chr16:2093680 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.594C>T (p.Ala198=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002357341]|not provided [RCV001405686] | Chr16:2043658 [GRCh38] Chr16:2093659 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.685+8G>A | single nucleotide variant | not provided [RCV001431259] | Chr16:2043559 [GRCh38] Chr16:2093560 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.745A>T (p.Lys249Ter) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV001533141] | Chr16:2040179 [GRCh38] Chr16:2090180 [GRCh37] Chr16:16p13.3 |
likely pathogenic |
NM_002528.7(NTHL1):c.736A>T (p.Lys246Ter) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003316841]|not provided [RCV001390301] | Chr16:2040188 [GRCh38] Chr16:2090189 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.87G>A (p.Gly29=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002438917]|not provided [RCV001399945] | Chr16:2047737 [GRCh38] Chr16:2097738 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.791+1G>A | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003469663]|Hereditary cancer-predisposing syndrome [RCV002420858]|NTHL1-related disorder [RCV004751966]|not provided [RCV001381694] | Chr16:2040132 [GRCh38] Chr16:2090133 [GRCh37] Chr16:16p13.3 |
pathogenic|likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance |
NM_002528.7(NTHL1):c.123G>A (p.Arg41=) | single nucleotide variant | not provided [RCV001447347] | Chr16:2046359 [GRCh38] Chr16:2096360 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.306G>A (p.Val102=) | single nucleotide variant | not provided [RCV001423562] | Chr16:2046176 [GRCh38] Chr16:2096177 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.564G>A (p.Leu188=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002358921]|not provided [RCV001411376] | Chr16:2043688 [GRCh38] Chr16:2093689 [GRCh37] Chr16:16p13.3 |
likely benign|conflicting interpretations of pathogenicity |
NM_002528.7(NTHL1):c.258A>G (p.Gln86=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002438953]|not provided [RCV001411476] | Chr16:2046224 [GRCh38] Chr16:2096225 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.84del (p.Pro30fs) | deletion | Familial adenomatous polyposis 3 [RCV003458227]|Hereditary cancer-predisposing syndrome [RCV004037691]|not provided [RCV001387870] | Chr16:2047740 [GRCh38] Chr16:2097741 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.540C>T (p.Tyr180=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002351002]|not provided [RCV001485810] | Chr16:2043712 [GRCh38] Chr16:2093713 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.129C>T (p.Ser43=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002405084]|not provided [RCV001461431] | Chr16:2046353 [GRCh38] Chr16:2096354 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.717C>T (p.Asn239=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002384823]|not provided [RCV001495349] | Chr16:2040207 [GRCh38] Chr16:2090208 [GRCh37] Chr16:16p13.3 |
likely benign|conflicting interpretations of pathogenicity |
NM_002528.7(NTHL1):c.177C>T (p.Ala59=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002421080]|not provided [RCV001473086] | Chr16:2046305 [GRCh38] Chr16:2096306 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.255G>A (p.Gln85=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002439155]|not provided [RCV001482224] | Chr16:2046227 [GRCh38] Chr16:2096228 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.360C>T (p.Arg120=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003160930]|not provided [RCV001476044] | Chr16:2044795 [GRCh38] Chr16:2094796 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_002528.7(NTHL1):c.18G>A (p.Ala6=) | single nucleotide variant | not provided [RCV001503281] | Chr16:2047806 [GRCh38] Chr16:2097807 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.526-8T>C | single nucleotide variant | not provided [RCV001497280] | Chr16:2043734 [GRCh38] Chr16:2093735 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.819C>T (p.Leu273=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002414165]|not provided [RCV001481113] | Chr16:2040020 [GRCh38] Chr16:2090021 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.75G>A (p.Arg25=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002384760]|not provided [RCV001471303] | Chr16:2047749 [GRCh38] Chr16:2097750 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.116-10C>T | single nucleotide variant | not provided [RCV001471333] | Chr16:2046376 [GRCh38] Chr16:2096377 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.87G>C (p.Gly29=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002439071]|not provided [RCV001454283] | Chr16:2047737 [GRCh38] Chr16:2097738 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.906G>A (p.Gln302=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002377658]|not provided [RCV001419084] | Chr16:2039933 [GRCh38] Chr16:2089934 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.307dup (p.Asp103fs) | duplication | Hereditary cancer-predisposing syndrome [RCV003169950]|not provided [RCV001387851] | Chr16:2046174..2046175 [GRCh38] Chr16:2096175..2096176 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.447G>T (p.Arg149=) | single nucleotide variant | not provided [RCV001464221] | Chr16:2044708 [GRCh38] Chr16:2094709 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.168G>A (p.Leu56=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003298813]|not provided [RCV001467345] | Chr16:2046314 [GRCh38] Chr16:2096315 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.160_161del (p.Gln54fs) | microsatellite | Familial adenomatous polyposis 3 [RCV003458228]|Hereditary cancer-predisposing syndrome [RCV003298633]|not provided [RCV001388535] | Chr16:2046321..2046322 [GRCh38] Chr16:2096322..2096323 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.843C>G (p.Thr281=) | single nucleotide variant | not provided [RCV001465816] | Chr16:2039996 [GRCh38] Chr16:2089997 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.375G>C (p.Leu125=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002324115]|not provided [RCV001506357] | Chr16:2044780 [GRCh38] Chr16:2094781 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_002528.7(NTHL1):c.159A>G (p.Ala53=) | single nucleotide variant | not provided [RCV001488567] | Chr16:2046323 [GRCh38] Chr16:2096324 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.115+9G>T | single nucleotide variant | not provided [RCV001476247] | Chr16:2047700 [GRCh38] Chr16:2097701 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.792-9C>A | single nucleotide variant | not provided [RCV001482415] | Chr16:2040056 [GRCh38] Chr16:2090057 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.357A>G (p.Val119=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002357316]|not provided [RCV001397720] | Chr16:2044798 [GRCh38] Chr16:2094799 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.686-5A>G | single nucleotide variant | not provided [RCV001461826] | Chr16:2040243 [GRCh38] Chr16:2090244 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.702G>A (p.Val234=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002384781]|not provided [RCV001480346] | Chr16:2040222 [GRCh38] Chr16:2090223 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.834C>T (p.Gly278=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002449091]|not provided [RCV001397792] | Chr16:2040005 [GRCh38] Chr16:2090006 [GRCh37] Chr16:16p13.3 |
likely benign|conflicting interpretations of pathogenicity |
NM_002528.7(NTHL1):c.603C>A (p.Ala201=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV004038650]|not provided [RCV001466063] | Chr16:2043649 [GRCh38] Chr16:2093650 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.402C>G (p.Thr134=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002329459]|not provided [RCV001419855] | Chr16:2044753 [GRCh38] Chr16:2094754 [GRCh37] Chr16:16p13.3 |
likely benign|conflicting interpretations of pathogenicity |
NM_002528.7(NTHL1):c.186C>G (p.Gly62=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002421137]|not provided [RCV001496546] | Chr16:2046296 [GRCh38] Chr16:2096297 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.39G>A (p.Arg13=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV004037795]|not provided [RCV001398477] | Chr16:2047785 [GRCh38] Chr16:2097786 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.216G>A (p.Glu72=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002456702]|not provided [RCV001428039] | Chr16:2046266 [GRCh38] Chr16:2096267 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.858C>T (p.His286=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002377696]|not provided [RCV001432930] | Chr16:2039981 [GRCh38] Chr16:2089982 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.69G>A (p.Gly23=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002377652]|not provided [RCV001416369] | Chr16:2047755 [GRCh38] Chr16:2097756 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.51C>T (p.Pro17=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002396109]|not provided [RCV001468122] | Chr16:2047773 [GRCh38] Chr16:2097774 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.459G>A (p.Val153=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003298820]|not provided [RCV001471655] | Chr16:2044696 [GRCh38] Chr16:2094697 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.373C>T (p.Leu125=) | single nucleotide variant | not provided [RCV001489073] | Chr16:2044782 [GRCh38] Chr16:2094783 [GRCh37] Chr16:16p13.3 |
likely benign|conflicting interpretations of pathogenicity |
NM_002528.7(NTHL1):c.792-5del | deletion | not provided [RCV001512169] | Chr16:2040052 [GRCh38] Chr16:2090053 [GRCh37] Chr16:16p13.3 |
benign |
NM_002528.7(NTHL1):c.897G>C (p.Pro299=) | single nucleotide variant | not provided [RCV001468200] | Chr16:2039942 [GRCh38] Chr16:2089943 [GRCh37] Chr16:16p13.3 |
likely benign |
GRCh37/hg19 16p13.3(chr16:2089795-2185919) | copy number loss | Polycystic kidney disease, adult type [RCV001535972] | Chr16:2089795..2185919 [GRCh37] Chr16:16p13.3 |
pathogenic |
NC_000016.9:g.(?_2034220)_(2152787_?)del | deletion | Tuberous sclerosis 2 [RCV003105244] | Chr16:2034220..2152787 [GRCh37] Chr16:16p13.3 |
pathogenic |
NC_000016.9:g.(?_2097690)_(2114448_?)del | deletion | Tuberous sclerosis 2 [RCV003105245] | Chr16:2097690..2114448 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.106G>T (p.Ala36Ser) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002258604] | Chr16:2047718 [GRCh38] Chr16:2097719 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.614C>A (p.Ala205Glu) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV002489789]|Hereditary cancer-predisposing syndrome [RCV002361038]|not provided [RCV001755092] | Chr16:2043638 [GRCh38] Chr16:2093639 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.10:g.1851807_2093151del | deletion | Tuberous sclerosis 2 [RCV001257345] | Chr16:1851807..2093151 [GRCh38] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.136C>T (p.Pro46Ser) | single nucleotide variant | not provided [RCV001756795] | Chr16:2046346 [GRCh38] Chr16:2096347 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.525+2T>G | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003470889]|Hereditary cancer-predisposing syndrome [RCV003355542]|not provided [RCV003238507] | Chr16:2044628 [GRCh38] Chr16:2094629 [GRCh37] Chr16:16p13.3 |
likely pathogenic |
NM_002528.7(NTHL1):c.239del (p.Glu80fs) | deletion | Hereditary cancer-predisposing syndrome [RCV002255965] | Chr16:2046243 [GRCh38] Chr16:2096244 [GRCh37] Chr16:16p13.3 |
likely pathogenic |
NM_002528.7(NTHL1):c.241_242insT (p.Pro81fs) | insertion | Hereditary cancer-predisposing syndrome [RCV002255966] | Chr16:2046240..2046241 [GRCh38] Chr16:2096241..2096242 [GRCh37] Chr16:16p13.3 |
likely pathogenic |
NM_002528.7(NTHL1):c.386T>C (p.Met129Thr) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002257313] | Chr16:2044769 [GRCh38] Chr16:2094770 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.247del (p.Asp83fs) | deletion | Hereditary cancer-predisposing syndrome [RCV002258606] | Chr16:2046235 [GRCh38] Chr16:2096236 [GRCh37] Chr16:16p13.3 |
likely pathogenic |
NM_002528.7(NTHL1):c.38G>T (p.Arg13Leu) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002259248] | Chr16:2047786 [GRCh38] Chr16:2097787 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.539A>G (p.Tyr180Cys) | single nucleotide variant | not provided [RCV001763627] | Chr16:2043713 [GRCh38] Chr16:2093714 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.384G>C (p.Leu128=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002324179]|not provided [RCV001772493] | Chr16:2044771 [GRCh38] Chr16:2094772 [GRCh37] Chr16:16p13.3 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_002528.7(NTHL1):c.-8A>C | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002414321]|not provided [RCV001769008] | Chr16:2047831 [GRCh38] Chr16:2097832 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.440G>T (p.Arg147Leu) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003298981]|not provided [RCV001769045] | Chr16:2044715 [GRCh38] Chr16:2094716 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.585C>T (p.Asp195=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002359235]|not provided [RCV001765270] | Chr16:2043667 [GRCh38] Chr16:2093668 [GRCh37] Chr16:16p13.3 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_002528.7(NTHL1):c.690G>A (p.Val230=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003163858]|not provided [RCV001765457] | Chr16:2040234 [GRCh38] Chr16:2090235 [GRCh37] Chr16:16p13.3 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_002528.7(NTHL1):c.220C>T (p.Leu74Phe) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV004516048] | Chr16:2046262 [GRCh38] Chr16:2096263 [GRCh37] Chr16:16p13.3 |
pathogenic|likely benign |
NM_002528.7(NTHL1):c.695C>A (p.Thr232Lys) | single nucleotide variant | not provided [RCV001757077] | Chr16:2040229 [GRCh38] Chr16:2090230 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.872C>A (p.Ala291Asp) | single nucleotide variant | not provided [RCV002022458] | Chr16:2039967 [GRCh38] Chr16:2089968 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.167T>C (p.Leu56Pro) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002407096]|not provided [RCV001949805] | Chr16:2046315 [GRCh38] Chr16:2096316 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.207G>C (p.Glu69Asp) | single nucleotide variant | not provided [RCV001915532] | Chr16:2046275 [GRCh38] Chr16:2096276 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.9:g.(?_2003468)_(2126543_?)del | deletion | Tuberous sclerosis 2 [RCV001949704] | Chr16:2003468..2126543 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.429G>C (p.Met143Ile) | single nucleotide variant | not provided [RCV001895760] | Chr16:2044726 [GRCh38] Chr16:2094727 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.532G>C (p.Val178Leu) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002344170]|not provided [RCV002006251] | Chr16:2043720 [GRCh38] Chr16:2093721 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.115+19T>G | single nucleotide variant | not provided [RCV001915406] | Chr16:2047690 [GRCh38] Chr16:2097691 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.717C>G (p.Asn239Lys) | single nucleotide variant | not provided [RCV001910382] | Chr16:2040207 [GRCh38] Chr16:2090208 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.237G>A (p.Trp79Ter) | single nucleotide variant | not provided [RCV001968034] | Chr16:2046245 [GRCh38] Chr16:2096246 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.25C>A (p.Leu9Met) | single nucleotide variant | not provided [RCV001895464] | Chr16:2047799 [GRCh38] Chr16:2097800 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.484G>A (p.Ala162Thr) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002337125]|not provided [RCV002045045] | Chr16:2044671 [GRCh38] Chr16:2094672 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.526-5T>C | single nucleotide variant | not provided [RCV001890561] | Chr16:2043731 [GRCh38] Chr16:2093732 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_002528.7(NTHL1):c.316G>A (p.Gly106Arg) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003164128]|not provided [RCV001874284] | Chr16:2046166 [GRCh38] Chr16:2096167 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.65G>T (p.Arg22Leu) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003289281]|not provided [RCV001969756] | Chr16:2047759 [GRCh38] Chr16:2097760 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.107C>A (p.Ala36Asp) | single nucleotide variant | not provided [RCV001890964] | Chr16:2047717 [GRCh38] Chr16:2097718 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.55G>A (p.Ala19Thr) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV004045331]|not provided [RCV001986125] | Chr16:2047769 [GRCh38] Chr16:2097770 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.11T>A (p.Leu4Ter) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003458235]|not provided [RCV001909047] | Chr16:2047813 [GRCh38] Chr16:2097814 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.32GGAGCC[1] (p.11RS[1]) | microsatellite | Hereditary cancer-predisposing syndrome [RCV002259152]|not provided [RCV001891630] | Chr16:2047781..2047786 [GRCh38] Chr16:2097782..2097787 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.912_913dup (p.Ter305SerextTer?) | microsatellite | Hereditary cancer-predisposing syndrome [RCV002258346]|not provided [RCV001965712] | Chr16:2039925..2039926 [GRCh38] Chr16:2089926..2089927 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.756G>T (p.Glu252Asp) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003161166]|not provided [RCV002004271] | Chr16:2040168 [GRCh38] Chr16:2090169 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.257A>G (p.Gln86Arg) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002441190]|not provided [RCV002022499] | Chr16:2046225 [GRCh38] Chr16:2096226 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.738G>C (p.Lys246Asn) | single nucleotide variant | not provided [RCV001968433] | Chr16:2040186 [GRCh38] Chr16:2090187 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.284G>A (p.Arg95Lys) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002324230]|not provided [RCV002039485] | Chr16:2046198 [GRCh38] Chr16:2096199 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.172G>A (p.Val58Met) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003355612]|not provided [RCV001890695] | Chr16:2046310 [GRCh38] Chr16:2096311 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.860C>G (p.Pro287Arg) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002370506]|not provided [RCV001909575] | Chr16:2039979 [GRCh38] Chr16:2089980 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.172_175del (p.Val58fs) | deletion | not provided [RCV001947081] | Chr16:2046307..2046310 [GRCh38] Chr16:2096308..2096311 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.675_676del (p.Ser226fs) | microsatellite | Familial adenomatous polyposis 3 [RCV004591684]|not provided [RCV002005756] | Chr16:2043576..2043577 [GRCh38] Chr16:2093577..2093578 [GRCh37] Chr16:16p13.3 |
pathogenic|likely pathogenic |
NM_002528.7(NTHL1):c.791G>C (p.Arg264Thr) | single nucleotide variant | not provided [RCV001913695] | Chr16:2040133 [GRCh38] Chr16:2090134 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.21G>C (p.Arg7Ser) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV004651914]|not provided [RCV002021502] | Chr16:2047803 [GRCh38] Chr16:2097804 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.526-1G>T | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003458232]|not provided [RCV001895351] | Chr16:2043727 [GRCh38] Chr16:2093728 [GRCh37] Chr16:16p13.3 |
pathogenic|likely pathogenic |
GRCh37/hg19 16p13.3(chr16:1830141-2592737)x3 | copy number gain | not provided [RCV001827737] | Chr16:1830141..2592737 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.709dup (p.Ile237fs) | duplication | Familial adenomatous polyposis 3 [RCV003458240]|Hereditary cancer-predisposing syndrome [RCV002386918]|not provided [RCV002020931] | Chr16:2040214..2040215 [GRCh38] Chr16:2090215..2090216 [GRCh37] Chr16:16p13.3 |
pathogenic|likely pathogenic |
NM_002528.7(NTHL1):c.625_626del (p.Val209fs) | microsatellite | Familial adenomatous polyposis 3 [RCV003458241]|not provided [RCV002020955] | Chr16:2043626..2043627 [GRCh38] Chr16:2093627..2093628 [GRCh37] Chr16:16p13.3 |
pathogenic|likely pathogenic |
NM_002528.7(NTHL1):c.905A>T (p.Gln302Leu) | single nucleotide variant | not provided [RCV001966929] | Chr16:2039934 [GRCh38] Chr16:2089935 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.586A>C (p.Ile196Leu) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003303584]|not provided [RCV001986341] | Chr16:2043666 [GRCh38] Chr16:2093667 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.377T>A (p.Leu126Gln) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV004044611]|not provided [RCV001970338] | Chr16:2044778 [GRCh38] Chr16:2094779 [GRCh37] Chr16:16p13.3 |
uncertain significance |
GRCh37/hg19 16p13.3(chr16:1847662-2653144) | copy number gain | not specified [RCV002052502] | Chr16:1847662..2653144 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.240_248del (p.Glu80_Gln82del) | deletion | not provided [RCV001913236] | Chr16:2046234..2046242 [GRCh38] Chr16:2096235..2096243 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.543C>G (p.Ile181Met) | single nucleotide variant | not provided [RCV001948553] | Chr16:2043709 [GRCh38] Chr16:2093710 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.218C>T (p.Pro73Leu) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002458855]|not provided [RCV001967672] | Chr16:2046264 [GRCh38] Chr16:2096265 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.295G>A (p.Asp99Asn) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV004041580]|not provided [RCV001887320] | Chr16:2046187 [GRCh38] Chr16:2096188 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.9:g.(?_2096119)_(2143097_?)dup | duplication | not provided [RCV001940140] | Chr16:2096119..2143097 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.568C>T (p.Gln190Ter) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003458237]|not provided [RCV001999770] | Chr16:2043684 [GRCh38] Chr16:2093685 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.17C>G (p.Ala6Gly) | single nucleotide variant | not provided [RCV001884701] | Chr16:2047807 [GRCh38] Chr16:2097808 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.508C>G (p.Pro170Ala) | single nucleotide variant | not provided [RCV001954688] | Chr16:2044647 [GRCh38] Chr16:2094648 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.115G>C (p.Glu39Gln) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002388792]|not provided [RCV001922570] | Chr16:2047709 [GRCh38] Chr16:2097710 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.81G>T (p.Glu27Asp) | single nucleotide variant | not provided [RCV001991382] | Chr16:2047743 [GRCh38] Chr16:2097744 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.75G>C (p.Arg25Ser) | single nucleotide variant | not provided [RCV001978836] | Chr16:2047749 [GRCh38] Chr16:2097750 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.854T>C (p.Val285Ala) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002370451]|not provided [RCV001884392] | Chr16:2039985 [GRCh38] Chr16:2089986 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.645C>G (p.His215Gln) | single nucleotide variant | not provided [RCV001988951] | Chr16:2043607 [GRCh38] Chr16:2093608 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.319A>G (p.Thr107Ala) | single nucleotide variant | not provided [RCV002000959] | Chr16:2046163 [GRCh38] Chr16:2096164 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.9:g.(?_2029297)_(2096295_?)del | deletion | not provided [RCV001958665] | Chr16:2029297..2096295 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.62C>G (p.Pro21Arg) | single nucleotide variant | not provided [RCV001939838] | Chr16:2047762 [GRCh38] Chr16:2097763 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.236G>T (p.Trp79Leu) | single nucleotide variant | not provided [RCV001886828] | Chr16:2046246 [GRCh38] Chr16:2096247 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.299C>T (p.Ala100Val) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003365482]|not provided [RCV001942525] | Chr16:2046183 [GRCh38] Chr16:2096184 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.574T>C (p.Tyr192His) | single nucleotide variant | not provided [RCV002037467] | Chr16:2043678 [GRCh38] Chr16:2093679 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.840G>T (p.Gln280His) | single nucleotide variant | not provided [RCV001976354] | Chr16:2039999 [GRCh38] Chr16:2090000 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.9:g.(?_2096109)_(2100507_?)del | deletion | Tuberous sclerosis 2 [RCV001942201] | Chr16:2096109..2100507 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.524G>A (p.Arg175Lys) | single nucleotide variant | not provided [RCV001877296] | Chr16:2044631 [GRCh38] Chr16:2094632 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.73A>G (p.Arg25Gly) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002370417]|not provided [RCV001900476] | Chr16:2047751 [GRCh38] Chr16:2097752 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_002528.7(NTHL1):c.874T>C (p.Cys292Arg) | single nucleotide variant | not provided [RCV002046629] | Chr16:2039965 [GRCh38] Chr16:2089966 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.382C>A (p.Leu128Met) | single nucleotide variant | not provided [RCV001917846] | Chr16:2044773 [GRCh38] Chr16:2094774 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.225G>T (p.Lys75Asn) | single nucleotide variant | not provided [RCV001921200] | Chr16:2046257 [GRCh38] Chr16:2096258 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.712_713delinsTT (p.Ala238Phe) | indel | Hereditary cancer-predisposing syndrome [RCV003170473]|not provided [RCV002028202] | Chr16:2040211..2040212 [GRCh38] Chr16:2090212..2090213 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.22A>G (p.Met8Val) | single nucleotide variant | not provided [RCV001974043] | Chr16:2047802 [GRCh38] Chr16:2097803 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.9:g.(?_256302)_(5971108_?)dup | duplication | Familial Mediterranean fever [RCV001877532]|Fanconi anemia [RCV001877533]|not provided [RCV001877531] | Chr16:256302..5971108 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.40A>C (p.Ser14Arg) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002361172]|not provided [RCV001898122] | Chr16:2047784 [GRCh38] Chr16:2097785 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.388C>G (p.Leu130Val) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003464282]|Hereditary cancer-predisposing syndrome [RCV002331518]|not provided [RCV001989959] | Chr16:2044767 [GRCh38] Chr16:2094768 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.196G>A (p.Glu66Lys) | single nucleotide variant | not provided [RCV001919353] | Chr16:2046286 [GRCh38] Chr16:2096287 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.842C>A (p.Thr281Asn) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002370636]|not provided [RCV001977477] | Chr16:2039997 [GRCh38] Chr16:2089998 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.256C>T (p.Gln86Ter) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003458236]|Hereditary cancer-predisposing syndrome [RCV002441011]|not provided [RCV001903865] | Chr16:2046226 [GRCh38] Chr16:2096227 [GRCh37] Chr16:16p13.3 |
pathogenic|likely pathogenic |
NM_002528.7(NTHL1):c.271A>G (p.Ile91Val) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV004571991]|Hereditary cancer-predisposing syndrome [RCV004046883]|not provided [RCV002027257] | Chr16:2046211 [GRCh38] Chr16:2096212 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.783G>C (p.Trp261Cys) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV004571571]|not provided [RCV001932716] | Chr16:2040141 [GRCh38] Chr16:2090142 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.792-2A>G | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002423060]|not provided [RCV001916984] | Chr16:2040049 [GRCh38] Chr16:2090050 [GRCh37] Chr16:16p13.3 |
likely pathogenic|uncertain significance |
NM_002528.7(NTHL1):c.330C>T (p.Cys110=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002256872]|not provided [RCV001956053] | Chr16:2046152 [GRCh38] Chr16:2096153 [GRCh37] Chr16:16p13.3 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_002528.7(NTHL1):c.533T>C (p.Val178Ala) | single nucleotide variant | not provided [RCV002016439] | Chr16:2043719 [GRCh38] Chr16:2093720 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.754GAG[1] (p.Glu253del) | microsatellite | not provided [RCV001875284] | Chr16:2040165..2040167 [GRCh38] Chr16:2090166..2090168 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.82C>G (p.Pro28Ala) | single nucleotide variant | not provided [RCV001917231] | Chr16:2047742 [GRCh38] Chr16:2097743 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.494G>A (p.Gly165Asp) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002337167]|not provided [RCV002031237] | Chr16:2044661 [GRCh38] Chr16:2094662 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.35G>A (p.Ser12Asn) | single nucleotide variant | not provided [RCV002015880] | Chr16:2047789 [GRCh38] Chr16:2097790 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.29C>T (p.Thr10Ile) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV004571608]|Hereditary cancer-predisposing syndrome [RCV002344032]|not provided [RCV001933063] | Chr16:2047795 [GRCh38] Chr16:2097796 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.282G>A (p.Met94Ile) | single nucleotide variant | not provided [RCV002046245] | Chr16:2046200 [GRCh38] Chr16:2096201 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.9:g.(?_2089925)_(2098774_?)del | deletion | Tuberous sclerosis 2 [RCV001955370] | Chr16:2089925..2098774 [GRCh37] Chr16:16p13.3 |
pathogenic |
NC_000016.9:g.(?_2097700)_(2129439_?)dup | duplication | Tuberous sclerosis 2 [RCV001916096] | Chr16:2097700..2129439 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.103G>A (p.Glu35Lys) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV004641816]|not provided [RCV001972336] | Chr16:2047721 [GRCh38] Chr16:2097722 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.242C>A (p.Pro81His) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV004043092]|not provided [RCV001936815] | Chr16:2046240 [GRCh38] Chr16:2096241 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.115+15T>C | single nucleotide variant | not provided [RCV001954032] | Chr16:2047694 [GRCh38] Chr16:2097695 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.589C>T (p.Pro197Ser) | single nucleotide variant | not provided [RCV001976501] | Chr16:2043663 [GRCh38] Chr16:2093664 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.790A>G (p.Arg264Gly) | single nucleotide variant | not provided [RCV001906845] | Chr16:2040134 [GRCh38] Chr16:2090135 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.726del (p.Arg242fs) | deletion | not provided [RCV001972553] | Chr16:2040198 [GRCh38] Chr16:2090199 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.762C>G (p.Thr254=) | single nucleotide variant | not provided [RCV001975294] | Chr16:2040162 [GRCh38] Chr16:2090163 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.442G>A (p.Ala148Thr) | single nucleotide variant | not provided [RCV001957610] | Chr16:2044713 [GRCh38] Chr16:2094714 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.9:g.(?_2034220)_(2136892_?)del | deletion | Tuberous sclerosis 2 [RCV001939677] | Chr16:2034220..2136892 [GRCh37] Chr16:16p13.3 |
pathogenic |
NC_000016.9:g.(?_2089925)_(2093737_?)del | deletion | not provided [RCV002048148] | Chr16:2089925..2093737 [GRCh37] Chr16:16p13.3 |
likely pathogenic |
NM_002528.7(NTHL1):c.698A>T (p.His233Leu) | single nucleotide variant | not provided [RCV001956708] | Chr16:2040226 [GRCh38] Chr16:2090227 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.674T>C (p.Val225Ala) | single nucleotide variant | not provided [RCV002018282] | Chr16:2043578 [GRCh38] Chr16:2093579 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.915A>G (p.Ter305Trp) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002370359]|not provided [RCV002046945] | Chr16:2039924 [GRCh38] Chr16:2089925 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.305T>G (p.Val102Gly) | single nucleotide variant | not provided [RCV001878999] | Chr16:2046177 [GRCh38] Chr16:2096178 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.620C>A (p.Pro207Gln) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003303671]|not provided [RCV002036203] | Chr16:2043632 [GRCh38] Chr16:2093633 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.469C>G (p.Leu157Val) | single nucleotide variant | not provided [RCV001975568] | Chr16:2044686 [GRCh38] Chr16:2094687 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.836A>G (p.Gln279Arg) | single nucleotide variant | not provided [RCV001956892] | Chr16:2040003 [GRCh38] Chr16:2090004 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.686-6C>T | single nucleotide variant | not provided [RCV001902131] | Chr16:2040244 [GRCh38] Chr16:2090245 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.913T>C (p.Ter305Arg) | single nucleotide variant | not provided [RCV001885912] | Chr16:2039926 [GRCh38] Chr16:2089927 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.418dup (p.Ala140fs) | duplication | Familial adenomatous polyposis 3 [RCV004043465]|Hereditary cancer-predisposing syndrome [RCV004043464]|not provided [RCV001932884] | Chr16:2044736..2044737 [GRCh38] Chr16:2094737..2094738 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.833G>A (p.Gly278Asp) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV004651846]|not provided [RCV001931658] | Chr16:2040006 [GRCh38] Chr16:2090007 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.457G>A (p.Val153Met) | single nucleotide variant | not provided [RCV001920986] | Chr16:2044698 [GRCh38] Chr16:2094699 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.653T>C (p.Met218Thr) | single nucleotide variant | not provided [RCV001883476] | Chr16:2043599 [GRCh38] Chr16:2093600 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.52G>T (p.Gly18Trp) | single nucleotide variant | not provided [RCV002036370] | Chr16:2047772 [GRCh38] Chr16:2097773 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.290A>C (p.Lys97Thr) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002324235]|not provided [RCV002047454] | Chr16:2046192 [GRCh38] Chr16:2096193 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.647T>C (p.Leu216Pro) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003365516]|not provided [RCV001898563] | Chr16:2043605 [GRCh38] Chr16:2093606 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.9:g.(?_2089925)_(2104451_?)del | deletion | Tuberous sclerosis 2 [RCV001960628] | Chr16:2089925..2104451 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.408C>A (p.Asp136Glu) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002331606]|not provided [RCV002011099] | Chr16:2044747 [GRCh38] Chr16:2094748 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.301C>T (p.Pro101Ser) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003289327]|not provided [RCV001975996] | Chr16:2046181 [GRCh38] Chr16:2096182 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.908G>A (p.Gly303Asp) | single nucleotide variant | not provided [RCV001973451] | Chr16:2039931 [GRCh38] Chr16:2089932 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.10:g.2047835G>A | single nucleotide variant | not provided [RCV001924211] | Chr16:2047835 [GRCh38] Chr16:2097836 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.612_637del (p.Ala205fs) | deletion | not provided [RCV002011307] | Chr16:2043615..2043640 [GRCh38] Chr16:2093616..2093641 [GRCh37] Chr16:16p13.3 |
likely pathogenic |
NM_002528.7(NTHL1):c.395G>A (p.Ser132Asn) | single nucleotide variant | not provided [RCV001930856] | Chr16:2044760 [GRCh38] Chr16:2094761 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.277G>A (p.Ala93Thr) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV004044121]|not provided [RCV001923826] | Chr16:2046205 [GRCh38] Chr16:2096206 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_002528.7(NTHL1):c.625G>T (p.Val209Phe) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002361110]|not provided [RCV001932076] | Chr16:2043627 [GRCh38] Chr16:2093628 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.107C>G (p.Ala36Gly) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003170357]|not provided [RCV001994282] | Chr16:2047717 [GRCh38] Chr16:2097718 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.116-13_172del | deletion | not provided [RCV002036094] | Chr16:2046310..2046379 [GRCh38] Chr16:2096311..2096380 [GRCh37] Chr16:16p13.3 |
likely pathogenic |
NM_002528.7(NTHL1):c.115+4G>T | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV004043619]|not provided [RCV001940436] | Chr16:2047705 [GRCh38] Chr16:2097706 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.3G>A (p.Met1Ile) | single nucleotide variant | not provided [RCV002036346] | Chr16:2047821 [GRCh38] Chr16:2097822 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.251G>T (p.Trp84Leu) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003161238]|not provided [RCV002018632] | Chr16:2046231 [GRCh38] Chr16:2096232 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.634A>C (p.Lys212Gln) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003458234]|Hereditary cancer-predisposing syndrome [RCV002370446]|not provided [RCV001905670] | Chr16:2043618 [GRCh38] Chr16:2093619 [GRCh37] Chr16:16p13.3 |
likely pathogenic|uncertain significance |
NM_002528.7(NTHL1):c.685+6T>C | single nucleotide variant | not provided [RCV001925247] | Chr16:2043561 [GRCh38] Chr16:2093562 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.10:g.2047843_2047859dup | duplication | not provided [RCV001898933] | Chr16:2047841..2047842 [GRCh38] Chr16:2097842..2097843 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.170G>C (p.Arg57Pro) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003375551]|not provided [RCV002028829] | Chr16:2046312 [GRCh38] Chr16:2096313 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.257A>T (p.Gln86Leu) | single nucleotide variant | not provided [RCV001973869] | Chr16:2046225 [GRCh38] Chr16:2096226 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.791+12T>C | single nucleotide variant | not provided [RCV001956520] | Chr16:2040121 [GRCh38] Chr16:2090122 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.890T>C (p.Leu297Pro) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002370709]|not provided [RCV002011563]|not specified [RCV003321893] | Chr16:2039949 [GRCh38] Chr16:2089950 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.215A>G (p.Glu72Gly) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002443080]|not provided [RCV002031639] | Chr16:2046267 [GRCh38] Chr16:2096268 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.449dup (p.Leu151fs) | duplication | not provided [RCV001974636] | Chr16:2044705..2044706 [GRCh38] Chr16:2094706..2094707 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.411G>C (p.Gln137His) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002331639]|not provided [RCV002027326] | Chr16:2044744 [GRCh38] Chr16:2094745 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.792-6C>A | single nucleotide variant | not provided [RCV001976721] | Chr16:2040053 [GRCh38] Chr16:2090054 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_002528.7(NTHL1):c.789dup (p.Arg264Ter) | duplication | not provided [RCV001973123] | Chr16:2040134..2040135 [GRCh38] Chr16:2090135..2090136 [GRCh37] Chr16:16p13.3 |
pathogenic|likely pathogenic |
NM_002528.7(NTHL1):c.704A>C (p.His235Pro) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003464370]|not provided [RCV001991935] | Chr16:2040220 [GRCh38] Chr16:2090221 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.799T>C (p.Trp267Arg) | single nucleotide variant | not provided [RCV001956717] | Chr16:2040040 [GRCh38] Chr16:2090041 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.9:g.(?_2089925)_(2090249_?)del | deletion | not provided [RCV002013604] | Chr16:2089925..2090249 [GRCh37] Chr16:16p13.3 |
likely pathogenic |
NM_002528.7(NTHL1):c.845G>A (p.Cys282Tyr) | single nucleotide variant | not provided [RCV001996233] | Chr16:2039994 [GRCh38] Chr16:2089995 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.4A>C (p.Thr2Pro) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV004571927]|Hereditary cancer-predisposing syndrome [RCV002441174]|not provided [RCV002012638] | Chr16:2047820 [GRCh38] Chr16:2097821 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.791+3A>G | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002423280]|not provided [RCV002030872] | Chr16:2040130 [GRCh38] Chr16:2090131 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.52G>C (p.Gly18Arg) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002397984]|not provided [RCV001953321] | Chr16:2047772 [GRCh38] Chr16:2097773 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.9:g.(?_2089925)_(2098066_?)del | deletion | Tuberous sclerosis 2 [RCV001900298] | Chr16:2089925..2098066 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.791G>A (p.Arg264Lys) | single nucleotide variant | not provided [RCV001975292] | Chr16:2040133 [GRCh38] Chr16:2090134 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.9:g.(?_2089925)_(2136390_?)dup | duplication | Tuberous sclerosis 2 [RCV001880693] | Chr16:2089925..2136390 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.142A>G (p.Lys48Glu) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002398088]|not provided [RCV002011047] | Chr16:2046340 [GRCh38] Chr16:2096341 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.560T>C (p.Ile187Thr) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002359346]|not provided [RCV001921954] | Chr16:2043692 [GRCh38] Chr16:2093693 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.732C>A (p.Thr244=) | single nucleotide variant | not provided [RCV002190204] | Chr16:2040192 [GRCh38] Chr16:2090193 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.685+17G>A | single nucleotide variant | not provided [RCV002129925]|not specified [RCV002465923] | Chr16:2043550 [GRCh38] Chr16:2093551 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.526-13C>T | single nucleotide variant | not provided [RCV002170205] | Chr16:2043739 [GRCh38] Chr16:2093740 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.116-11G>A | single nucleotide variant | not provided [RCV002187536] | Chr16:2046377 [GRCh38] Chr16:2096378 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.685+13G>C | single nucleotide variant | not provided [RCV002210279] | Chr16:2043554 [GRCh38] Chr16:2093555 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.685+14G>A | single nucleotide variant | not provided [RCV002187584] | Chr16:2043553 [GRCh38] Chr16:2093554 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.792-5C>T | single nucleotide variant | not provided [RCV002148500] | Chr16:2040052 [GRCh38] Chr16:2090053 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.355-14C>T | single nucleotide variant | not provided [RCV002108929] | Chr16:2044814 [GRCh38] Chr16:2094815 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.115+8C>G | single nucleotide variant | not provided [RCV002146798] | Chr16:2047701 [GRCh38] Chr16:2097702 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.108T>G (p.Ala36=) | single nucleotide variant | not provided [RCV002210693] | Chr16:2047716 [GRCh38] Chr16:2097717 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.791+18dup | duplication | not provided [RCV002129168] | Chr16:2040114..2040115 [GRCh38] Chr16:2090115..2090116 [GRCh37] Chr16:16p13.3 |
benign |
NM_002528.7(NTHL1):c.685+11G>T | single nucleotide variant | not provided [RCV002086253] | Chr16:2043556 [GRCh38] Chr16:2093557 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.33G>T (p.Arg11=) | single nucleotide variant | not provided [RCV002167344] | Chr16:2047791 [GRCh38] Chr16:2097792 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.720G>A (p.Arg240=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003289415]|not provided [RCV002071046] | Chr16:2040204 [GRCh38] Chr16:2090205 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.354+13C>T | single nucleotide variant | not provided [RCV002146222] | Chr16:2046115 [GRCh38] Chr16:2096116 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.354+16_354+19dup | duplication | not provided [RCV002209544]|not specified [RCV002268604] | Chr16:2046108..2046109 [GRCh38] Chr16:2096109..2096110 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.355-9C>T | single nucleotide variant | not provided [RCV002189826] | Chr16:2044809 [GRCh38] Chr16:2094810 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.63G>A (p.Pro21=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002372979]|not provided [RCV002106578] | Chr16:2047761 [GRCh38] Chr16:2097762 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.558C>G (p.Ala186=) | single nucleotide variant | not provided [RCV002088609] | Chr16:2043694 [GRCh38] Chr16:2093695 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.685+12A>G | single nucleotide variant | not provided [RCV002071241] | Chr16:2043555 [GRCh38] Chr16:2093556 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.390C>T (p.Leu130=) | single nucleotide variant | not provided [RCV002073813] | Chr16:2044765 [GRCh38] Chr16:2094766 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.525+17G>A | single nucleotide variant | not provided [RCV002091851] | Chr16:2044613 [GRCh38] Chr16:2094614 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.249C>T (p.Asp83=) | single nucleotide variant | not provided [RCV002210713] | Chr16:2046233 [GRCh38] Chr16:2096234 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.354+20G>A | single nucleotide variant | not provided [RCV002165530] | Chr16:2046108 [GRCh38] Chr16:2096109 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.402C>T (p.Thr134=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002331769]|not provided [RCV002074549] | Chr16:2044753 [GRCh38] Chr16:2094754 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.51C>G (p.Pro17=) | single nucleotide variant | not provided [RCV002084760] | Chr16:2047773 [GRCh38] Chr16:2097774 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.210G>A (p.Gly70=) | single nucleotide variant | not provided [RCV002168913] | Chr16:2046272 [GRCh38] Chr16:2096273 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.780G>A (p.Glu260=) | single nucleotide variant | not provided [RCV002206590] | Chr16:2040144 [GRCh38] Chr16:2090145 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.526-16C>G | single nucleotide variant | not provided [RCV002108043] | Chr16:2043742 [GRCh38] Chr16:2093743 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.528C>T (p.Ser176=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002346542]|not provided [RCV002188724] | Chr16:2043724 [GRCh38] Chr16:2093725 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.791+16G>C | single nucleotide variant | not provided [RCV002109854] | Chr16:2040117 [GRCh38] Chr16:2090118 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.686-15T>C | single nucleotide variant | not provided [RCV002130062] | Chr16:2040253 [GRCh38] Chr16:2090254 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.561C>T (p.Ile187=) | single nucleotide variant | not provided [RCV002079625] | Chr16:2043691 [GRCh38] Chr16:2093692 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.646C>T (p.Leu216=) | single nucleotide variant | not provided [RCV002096836] | Chr16:2043606 [GRCh38] Chr16:2093607 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.525+10G>A | single nucleotide variant | not provided [RCV002146153] | Chr16:2044620 [GRCh38] Chr16:2094621 [GRCh37] Chr16:16p13.3 |
likely benign|conflicting interpretations of pathogenicity |
NM_002528.7(NTHL1):c.792-11del | deletion | not provided [RCV002212289] | Chr16:2040058 [GRCh38] Chr16:2090059 [GRCh37] Chr16:16p13.3 |
benign |
NM_002528.7(NTHL1):c.791+13G>A | single nucleotide variant | not provided [RCV002191751] | Chr16:2040120 [GRCh38] Chr16:2090121 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.897G>T (p.Pro299=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002372855]|not provided [RCV002187292] | Chr16:2039942 [GRCh38] Chr16:2089943 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.116-12T>C | single nucleotide variant | not provided [RCV002172750] | Chr16:2046378 [GRCh38] Chr16:2096379 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.696G>T (p.Thr232=) | single nucleotide variant | not provided [RCV002193581] | Chr16:2040228 [GRCh38] Chr16:2090229 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.354+8G>A | single nucleotide variant | not provided [RCV002071385] | Chr16:2046120 [GRCh38] Chr16:2096121 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.207G>A (p.Glu69=) | single nucleotide variant | not provided [RCV002085063] | Chr16:2046275 [GRCh38] Chr16:2096276 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.300A>G (p.Ala100=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV004641940]|not provided [RCV002196416] | Chr16:2046182 [GRCh38] Chr16:2096183 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.115+17G>A | single nucleotide variant | not provided [RCV002115021]|not specified [RCV002268624] | Chr16:2047692 [GRCh38] Chr16:2097693 [GRCh37] Chr16:16p13.3 |
benign|likely benign |
NM_002528.7(NTHL1):c.702G>T (p.Val234=) | single nucleotide variant | not provided [RCV002093253] | Chr16:2040222 [GRCh38] Chr16:2090223 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.-7G>A | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV004045841]|not provided [RCV002117146] | Chr16:2047830 [GRCh38] Chr16:2097831 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.234C>T (p.Val78=) | single nucleotide variant | not provided [RCV002197139] | Chr16:2046248 [GRCh38] Chr16:2096249 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.115+7C>T | single nucleotide variant | not provided [RCV002216109] | Chr16:2047702 [GRCh38] Chr16:2097703 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.513C>A (p.Val171=) | single nucleotide variant | not provided [RCV002131527] | Chr16:2044642 [GRCh38] Chr16:2094643 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.116-20C>A | single nucleotide variant | not provided [RCV002211607] | Chr16:2046386 [GRCh38] Chr16:2096387 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.792-19C>G | single nucleotide variant | not provided [RCV002173616] | Chr16:2040066 [GRCh38] Chr16:2090067 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.526-11C>T | single nucleotide variant | not provided [RCV002152329] | Chr16:2043737 [GRCh38] Chr16:2093738 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.791+17G>A | single nucleotide variant | not provided [RCV002095939] | Chr16:2040116 [GRCh38] Chr16:2090117 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.525+14G>A | single nucleotide variant | not provided [RCV002150420] | Chr16:2044616 [GRCh38] Chr16:2094617 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.792-16_792-11dup | duplication | not provided [RCV002115094] | Chr16:2040057..2040058 [GRCh38] Chr16:2090058..2090059 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.791+16G>A | single nucleotide variant | not provided [RCV002146011] | Chr16:2040117 [GRCh38] Chr16:2090118 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.489G>T (p.Thr163=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003161622]|not provided [RCV002129063] | Chr16:2044666 [GRCh38] Chr16:2094667 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.792-11C>A | single nucleotide variant | not provided [RCV002115261] | Chr16:2040058 [GRCh38] Chr16:2090059 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.792-11C>T | single nucleotide variant | not provided [RCV002133209] | Chr16:2040058 [GRCh38] Chr16:2090059 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.354+9G>C | single nucleotide variant | not provided [RCV002195533] | Chr16:2046119 [GRCh38] Chr16:2096120 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.686-11C>T | single nucleotide variant | not provided [RCV002114045] | Chr16:2040249 [GRCh38] Chr16:2090250 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.888C>T (p.Ala296=) | single nucleotide variant | not provided [RCV002151950] | Chr16:2039951 [GRCh38] Chr16:2089952 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.686-18C>T | single nucleotide variant | not provided [RCV002215611] | Chr16:2040256 [GRCh38] Chr16:2090257 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.660G>A (p.Val220=) | single nucleotide variant | not provided [RCV002194862] | Chr16:2043592 [GRCh38] Chr16:2093593 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.686-17G>C | single nucleotide variant | not provided [RCV002073850] | Chr16:2040255 [GRCh38] Chr16:2090256 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.355-17T>C | single nucleotide variant | not provided [RCV002097856] | Chr16:2044817 [GRCh38] Chr16:2094818 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.468C>A (p.Ile156=) | single nucleotide variant | not provided [RCV002141264] | Chr16:2044687 [GRCh38] Chr16:2094688 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.669C>T (p.Gly223=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002361449]|not provided [RCV002200331] | Chr16:2043583 [GRCh38] Chr16:2093584 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_002528.7(NTHL1):c.45G>T (p.Leu15=) | single nucleotide variant | not provided [RCV002221107] | Chr16:2047779 [GRCh38] Chr16:2097780 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.686-17G>A | single nucleotide variant | not provided [RCV002142704] | Chr16:2040255 [GRCh38] Chr16:2090256 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.234dup (p.Trp79fs) | duplication | Hereditary cancer-predisposing syndrome [RCV002257312] | Chr16:2046247..2046248 [GRCh38] Chr16:2096248..2096249 [GRCh37] Chr16:16p13.3 |
likely pathogenic |
NM_002528.7(NTHL1):c.135C>T (p.Ser45=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002258605] | Chr16:2046347 [GRCh38] Chr16:2096348 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.759G>A (p.Glu253=) | single nucleotide variant | not provided [RCV002176916] | Chr16:2040165 [GRCh38] Chr16:2090166 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.686-18C>A | single nucleotide variant | not provided [RCV002153966] | Chr16:2040256 [GRCh38] Chr16:2090257 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.435A>G (p.Arg145=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV003355821]|not provided [RCV002154318] | Chr16:2044720 [GRCh38] Chr16:2094721 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.354+11G>A | single nucleotide variant | not provided [RCV002160125] | Chr16:2046117 [GRCh38] Chr16:2096118 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.42C>T (p.Ser14=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002361453]|not provided [RCV002198180] | Chr16:2047782 [GRCh38] Chr16:2097783 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.685+16C>T | single nucleotide variant | not provided [RCV002139601] | Chr16:2043551 [GRCh38] Chr16:2093552 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.451C>T (p.Leu151=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002337364]|not provided [RCV002136074] | Chr16:2044704 [GRCh38] Chr16:2094705 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.685+8G>C | single nucleotide variant | not provided [RCV002217315] | Chr16:2043559 [GRCh38] Chr16:2093560 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.791+13G>T | single nucleotide variant | not provided [RCV002084389] | Chr16:2040120 [GRCh38] Chr16:2090121 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.792-14C>T | single nucleotide variant | not provided [RCV002140171] | Chr16:2040061 [GRCh38] Chr16:2090062 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.115+14G>A | single nucleotide variant | not provided [RCV002142156] | Chr16:2047695 [GRCh38] Chr16:2097696 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.768C>A (p.Ala256=) | single nucleotide variant | not provided [RCV002183955] | Chr16:2040156 [GRCh38] Chr16:2090157 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.84C>T (p.Pro28=) | single nucleotide variant | not provided [RCV002099084] | Chr16:2047740 [GRCh38] Chr16:2097741 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.492G>T (p.Leu164=) | single nucleotide variant | not provided [RCV002164555] | Chr16:2044663 [GRCh38] Chr16:2094664 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.582G>T (p.Gly194=) | single nucleotide variant | not provided [RCV002159253] | Chr16:2043670 [GRCh38] Chr16:2093671 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.672T>C (p.Thr224=) | single nucleotide variant | not provided [RCV002159276] | Chr16:2043580 [GRCh38] Chr16:2093581 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.405A>G (p.Lys135=) | single nucleotide variant | not provided [RCV002157513] | Chr16:2044750 [GRCh38] Chr16:2094751 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.355-6A>G | single nucleotide variant | not provided [RCV002157812] | Chr16:2044806 [GRCh38] Chr16:2094807 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.526-12C>A | single nucleotide variant | not provided [RCV002180516] | Chr16:2043738 [GRCh38] Chr16:2093739 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.116-13G>T | single nucleotide variant | not provided [RCV002081729] | Chr16:2046379 [GRCh38] Chr16:2096380 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.355-20C>T | single nucleotide variant | not provided [RCV002100533] | Chr16:2044820 [GRCh38] Chr16:2094821 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.792-19C>T | single nucleotide variant | not provided [RCV002182991] | Chr16:2040066 [GRCh38] Chr16:2090067 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.171T>C (p.Arg57=) | single nucleotide variant | not provided [RCV002083932] | Chr16:2046311 [GRCh38] Chr16:2096312 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.685+20G>A | single nucleotide variant | not provided [RCV002084132] | Chr16:2043547 [GRCh38] Chr16:2093548 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.156A>G (p.Lys52=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV004046405]|not provided [RCV002158121] | Chr16:2046326 [GRCh38] Chr16:2096327 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.116-16G>A | single nucleotide variant | not provided [RCV002179443]|not specified [RCV002268600] | Chr16:2046382 [GRCh38] Chr16:2096383 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_002528.7(NTHL1):c.526-12C>G | single nucleotide variant | not provided [RCV002156118] | Chr16:2043738 [GRCh38] Chr16:2093739 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.231A>G (p.Pro77=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002256925]|not provided [RCV002183399] | Chr16:2046251 [GRCh38] Chr16:2096252 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.354+11G>C | single nucleotide variant | not provided [RCV002159731] | Chr16:2046117 [GRCh38] Chr16:2096118 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.791+13G>C | single nucleotide variant | not provided [RCV002141719] | Chr16:2040120 [GRCh38] Chr16:2090121 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.355-11T>G | single nucleotide variant | not provided [RCV002157377] | Chr16:2044811 [GRCh38] Chr16:2094812 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.116-11G>T | single nucleotide variant | not provided [RCV002139954] | Chr16:2046377 [GRCh38] Chr16:2096378 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.791+14G>A | single nucleotide variant | not provided [RCV002182267] | Chr16:2040119 [GRCh38] Chr16:2090120 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.738G>A (p.Lys246=) | single nucleotide variant | not provided [RCV002204459] | Chr16:2040186 [GRCh38] Chr16:2090187 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.372G>A (p.Val124=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002352914]|not provided [RCV002138673] | Chr16:2044783 [GRCh38] Chr16:2094784 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NC_000016.9:g.(?_256302)_(4852572_?)dup | duplication | Epilepsy [RCV003113403]|Idiopathic generalized epilepsy [RCV003109446]|Saldino-Mainzer syndrome [RCV003113404] | Chr16:256302..4852572 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.9:g.(?_2093548)_(2113074_?)del | deletion | Tuberous sclerosis 2 [RCV003111426] | Chr16:2093548..2113074 [GRCh37] Chr16:16p13.3 |
pathogenic |
NC_000016.9:g.(?_2089925)_(2105540_?)del | deletion | Tuberous sclerosis 2 [RCV003111427] | Chr16:2089925..2105540 [GRCh37] Chr16:16p13.3 |
pathogenic |
NC_000016.9:g.(?_2089925)_(2107460_?)del | deletion | Tuberous sclerosis 2 [RCV003111428] | Chr16:2089925..2107460 [GRCh37] Chr16:16p13.3 |
pathogenic |
NC_000016.9:g.(?_2089925)_(2114438_?)dup | duplication | Tuberous sclerosis 2 [RCV003111437] | Chr16:2089925..2114438 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.9:g.(?_2089925)_(2100497_?)dup | duplication | Tuberous sclerosis 2 [RCV003111438] | Chr16:2089925..2100497 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.9:g.(?_2089925)_(2131809_?)dup | duplication | Tuberous sclerosis 2 [RCV003111439] | Chr16:2089925..2131809 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.9:g.(?_2093548)_(2104461_?)dup | duplication | Tuberous sclerosis 2 [RCV003111440] | Chr16:2093548..2104461 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.9:g.(?_2079753)_(2100460_?)del | deletion | Tuberous sclerosis 2 [RCV003111445] | Chr16:2079753..2100460 [GRCh37] Chr16:16p13.3 |
pathogenic |
NC_000016.9:g.(?_2089925)_(2098067_?)dup | duplication | Tuberous sclerosis 2 [RCV003105249] | Chr16:2089925..2098067 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.616C>T (p.Leu206=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002257315]|not provided [RCV003107975] | Chr16:2043636 [GRCh38] Chr16:2093637 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_002528.7(NTHL1):c.229C>T (p.Pro77Ser) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002257311] | Chr16:2046253 [GRCh38] Chr16:2096254 [GRCh37] Chr16:16p13.3 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_002528.7(NTHL1):c.314T>C (p.Leu105Pro) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002258607] | Chr16:2046168 [GRCh38] Chr16:2096169 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.749C>T (p.Ser250Phe) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002257316] | Chr16:2040175 [GRCh38] Chr16:2090176 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.355-37C>T | single nucleotide variant | not specified [RCV002269031] | Chr16:2044837 [GRCh38] Chr16:2094838 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.225G>C (p.Lys75Asn) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002427745]|not specified [RCV002269033] | Chr16:2046257 [GRCh38] Chr16:2096258 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NC_000016.10:g.2047157_2220112del | deletion | Tuberous sclerosis 2 [RCV002267195] | Chr16:2047157..2220112 [GRCh38] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.*30T>C | single nucleotide variant | not specified [RCV002269026] | Chr16:2039894 [GRCh38] Chr16:2089895 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.115+24C>T | single nucleotide variant | not specified [RCV002269034] | Chr16:2047685 [GRCh38] Chr16:2097686 [GRCh37] Chr16:16p13.3 |
likely benign |
GRCh37/hg19 16p13.3(chr16:111043-6627459)x3 | copy number gain | See cases [RCV002292215] | Chr16:111043..6627459 [GRCh37] Chr16:16p13.3 |
pathogenic |
NC_000016.10:g.1903155_2093402del | deletion | Tuberous sclerosis 2 [RCV002267197] | Chr16:1903155..2093402 [GRCh38] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.526-44G>C | single nucleotide variant | not specified [RCV002269029] | Chr16:2043770 [GRCh38] Chr16:2093771 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.261G>A (p.Gln87=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002435466] | Chr16:2046221 [GRCh38] Chr16:2096222 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.339C>T (p.Ser113=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002452416] | Chr16:2046143 [GRCh38] Chr16:2096144 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.778G>A (p.Glu260Lys) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003464489]|Hereditary cancer-predisposing syndrome [RCV002419288]|not provided [RCV003560987] | Chr16:2040146 [GRCh38] Chr16:2090147 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.12G>A (p.Leu4=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002348908] | Chr16:2047812 [GRCh38] Chr16:2097813 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.341G>C (p.Ser114Thr) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002452545]|not provided [RCV003094284] | Chr16:2046141 [GRCh38] Chr16:2096142 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.787C>T (p.Pro263Ser) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002421281] | Chr16:2040137 [GRCh38] Chr16:2090138 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.276T>G (p.Arg92=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002435775] | Chr16:2046206 [GRCh38] Chr16:2096207 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.246G>A (p.Gln82=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002437442] | Chr16:2046236 [GRCh38] Chr16:2096237 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.531G>A (p.Lys177=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002351981] | Chr16:2043721 [GRCh38] Chr16:2093722 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.11T>G (p.Leu4Trp) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002455198]|not provided [RCV003099609] | Chr16:2047813 [GRCh38] Chr16:2097814 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.526-12_526-11del | deletion | not specified [RCV002269028] | Chr16:2043737..2043738 [GRCh38] Chr16:2093738..2093739 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.355-34G>A | single nucleotide variant | not specified [RCV002269030] | Chr16:2044834 [GRCh38] Chr16:2094835 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.309C>T (p.Asp103=) | single nucleotide variant | not specified [RCV002269032] | Chr16:2046173 [GRCh38] Chr16:2096174 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.643C>T (p.His215Tyr) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002367005] | Chr16:2043609 [GRCh38] Chr16:2093610 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.334G>T (p.Asp112Tyr) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002455131] | Chr16:2046148 [GRCh38] Chr16:2096149 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.641C>T (p.Ala214Val) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002366893]|not provided [RCV003098324] | Chr16:2043611 [GRCh38] Chr16:2093612 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.610G>T (p.Val204Leu) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002368975] | Chr16:2043642 [GRCh38] Chr16:2093643 [GRCh37] Chr16:16p13.3 |
uncertain significance |
GRCh37/hg19 16p13.3(chr16:2021144-2266791)x1 | copy number loss | not provided [RCV002472534] | Chr16:2021144..2266791 [GRCh37] Chr16:16p13.3 |
pathogenic |
NM_002528.7(NTHL1):c.278C>T (p.Ala93Val) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002435984]|not provided [RCV003102989] | Chr16:2046204 [GRCh38] Chr16:2096205 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.6(NTHL1):c.2T>G (p.Met1Arg) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002435653]|not provided [RCV003102963] | Chr16:2047846 [GRCh38] Chr16:2097847 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.639G>A (p.Met213Ile) | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003464477]|Hereditary cancer-predisposing syndrome [RCV002366793]|not provided [RCV003688981] | Chr16:2043613 [GRCh38] Chr16:2093614 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.792-1G>A | single nucleotide variant | Familial adenomatous polyposis 3 [RCV003471361]|Hereditary cancer-predisposing syndrome [RCV002421437]|not provided [RCV003669292] | Chr16:2040048 [GRCh38] Chr16:2090049 [GRCh37] Chr16:16p13.3 |
likely pathogenic|uncertain significance |
NM_002528.7(NTHL1):c.323A>G (p.Glu108Gly) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002454624]|not provided [RCV002299324] | Chr16:2046159 [GRCh38] Chr16:2096160 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.354+4G>C | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002351142] | Chr16:2046124 [GRCh38] Chr16:2096125 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.725G>A (p.Arg242Lys) | single nucleotide variant | not provided [RCV002297550] | Chr16:2040199 [GRCh38] Chr16:2090200 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.792-4A>C | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002421444] | Chr16:2040051 [GRCh38] Chr16:2090052 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.792-5C>A | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002421447]|not provided [RCV003099852] | Chr16:2040052 [GRCh38] Chr16:2090053 [GRCh37] Chr16:16p13.3 |
likely benign|uncertain significance |
NM_002528.7(NTHL1):c.792-5C>G | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002421448] | Chr16:2040052 [GRCh38] Chr16:2090053 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.646C>G (p.Leu216Val) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002367194] | Chr16:2043606 [GRCh38] Chr16:2093607 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.479ATG[1] (p.Asp161del) | microsatellite | Hereditary cancer-predisposing syndrome [RCV002351442]|not provided [RCV003688978] | Chr16:2044671..2044673 [GRCh38] Chr16:2094672..2094674 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.30C>A (p.Thr10=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002351627]|not provided [RCV003096771] | Chr16:2047794 [GRCh38] Chr16:2097795 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.792G>A (p.Arg264=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002421476] | Chr16:2040047 [GRCh38] Chr16:2090048 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.30C>T (p.Thr10=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002351634] | Chr16:2047794 [GRCh38] Chr16:2097795 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.526-2A>G | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002351678] | Chr16:2043728 [GRCh38] Chr16:2093729 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.604G>C (p.Glu202Gln) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002368736] | Chr16:2043648 [GRCh38] Chr16:2093649 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.240G>A (p.Glu80=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002453054] | Chr16:2046242 [GRCh38] Chr16:2096243 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.517T>G (p.Phe173Val) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002349494] | Chr16:2044638 [GRCh38] Chr16:2094639 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.343G>C (p.Ala115Pro) | single nucleotide variant | not provided [RCV002681456] | Chr16:2046139 [GRCh38] Chr16:2096140 [GRCh37] Chr16:16p13.3 |
uncertain significance |
NM_002528.7(NTHL1):c.543C>T (p.Ile181=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002347410] | Chr16:2043709 [GRCh38] Chr16:2093710 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.526-36del | deletion | not specified [RCV002466158] | Chr16:2043762 [GRCh38] Chr16:2093763 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.*31G>A | single nucleotide variant | not specified [RCV002466155] | Chr16:2039893 [GRCh38] Chr16:2089894 [GRCh37] Chr16:16p13.3 |
likely benign |
NM_002528.7(NTHL1):c.436C>T (p.Leu146=) | single nucleotide variant | Hereditary cancer-predisposing syndrome [RCV002342439] | Chr16:2044719 [GRCh38] Chr16:2094720 [GRCh37] Chr16:16p13.3 |
likely benign |